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Zusammenfassung 
 
Peroxisomaler Proteinimport erfolgt mit Hilfe einer speziellen Translokalisations-Machinerie 
an der peroxisomalen Membran. Obwohl die beteiligten Proteine während der letzten Jahre 
identifiziert wurden, sind Details zum Mechanismus der Translokalisation noch nicht bekannt. 
Aktuelle Ergebnisse lassen auf ein „cycling receptor“ Model schließen, welches aus „cargo 
recognition“ (der Aufnahme von peroxisomalen Matrixproteinen im Cytosol), dem 
„docking“, der Abgabe der aufgenommen Proteine ins peroxisomalen Lumen und dem 
Rezeptor Recycling besteht.   
Das membranassozierte Peroxin Pex14p wird im Allgemeinen als eine Hauptkomponente des 
peroxisomalen „Docking“-Komplexes angesehen. Es interagiert neben einigen 
membrangebundenen Peroxinen mit den PTS-Rezeptoren Pex5p und Pex7p und besteht aus 
drei Domänen: einem konservierten N-terminus, einer hydrophoben Region und einer coiled-
coil Domäne. Die N-terminale Domäne erkennt sogenannte WxxxF/Y-Motive, konservierte 
aromatische Sequenzen im PTS1-Rezeptor Pex5p. Obwohl es kein klassisches WxxxF/Y 
Motiv aufweist bindet Pex19p, ein Protein mit einer Schlüsselfunktion in der peroxisomalen 
Biogenese, dieselbe N-terminale Domäne von Pex14p wie Pex5p.  
In der vorliegenden Arbeit wurden funktionelle und strukturelle Studien am N-terminalen Tel 
von Pex14p durchgeführt. Die erhaltenen 3-dimensionalen Modelle beschreiben ein 3-Helix 
Bündel, das eine hydrophobe Interaktionsfläche für amphipatische, helikale Liganden 
darstellt. Der Vergleich zwischen der Komplexstruktur von Pex14p (aa 16-80W)-Pex5p (aa 
116-124) mit der von Pex14p (aa 16-80W)-Pex19p (aa 66-77) zeigt dass beide die gleich 
Bindestelle besetzen, wobei Pex19p eine unerwartete invertierte Orientierung aufweist. Die 
Strukturdaten wurden durch NMR Titrations- und ITC-Experimente ergänzt, welche die 
kompetitive Bindung von Pex5p und Pex19p bestätigten und Pex5p als den stärkeren 
Liganden charakterisieren. Die so gewonnen Ergebnisse erlauben einen Einblick in die 
molekularen Abläufe während der frühen Schritte des peroxisomalen Imports und implizieren 
Voraussetzungen die mögliche Pex14p-Interaktionspartner erfüllen sollten.  
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Abstract 
 
Peroxisomal matrix protein import is mediated by a distinct translocation machinery at the 
peroxisomal membrane. Although the components involved have been identified during the 
last years, details of the translocation mechanism are still unknown. Current evidence favour a 
cycling receptor model, consisting of cytosolic cargo recognition, docking, cargo release and 
receptor recycling. The membrane associated peroxin Pex14p has been proposed as a main 
component of the peroxisomal docking complex. It interacts with the PTS receptors as well as 
with several membrane-bound peroxins. Pex14p consist of three major domains, e.g. a 
conserved N-terminus, a hydrophobic region and a coiled coil domain. The N-terminal 
domain recognizes a conserved aromatic motif which is part of the PTS1 receptor Pex5p and 
called WxxxF/Y motif (Saidowsky et al 1999). Although the peroxisomal biogenesis factor 
Pex19p has no classical WxxxF/Y motif, it has been described as interacting with the same N-
terminal domain of Pex14p as Pex5p (Fransen et al. 2004). This work presents functional und 
structural studies of the N-terminus of Pex14p. The obtained 3-dimensional models describe a 
three-helical-bundle providing a hydrophobic interaction surface for an amphipathic, helical 
ligand. Comparison of the N-Pex14p-Pex5p and N-Pex14p-Pex19p complex structure shows 
that both ligands occupy the same binding pocket, wherein Pex19p exerts an unexpected 
reverse orientation. The structural data was supplemented with NMR titration and ITC data 
confirming the binding of Pex5p and Pex19p as competitive and characterizing Pex5p as the 
stronger ligand. These results provide insights into the molecular recognition mechanisms of 
the early steps of peroxisomal import and might implicate prerequisites for possible 
interaction partners of Pex14p. 
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Abbreviations 
 
Å   Ångström (1x10-10m) 
AAA    ATPases associated with diverse cellular activities  
ATP   adenosine tri phosphate 
B   strength of an external magnetic field 
DNA   desoxyribonucleic acid 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetic acid 
ER   endoplasmatic reticulum 
HEPES  N-(2-hydroxyethyl)piperazine-N’-2-ethanesulfonic acid 
His6    hexahistidine 
H.polymorpha, Hp Hansuela polymorpha 
HSQC   heteronuclear single quantum coherence spectroscopy  
γ   gyromagnetic ratio 
I   spin angular momentum (vector) 
I   spin quantum number 
IPTG    isopropyl-β-D-thiogalactopyranoside  
ITC   isothermal titration microcalorimetry  
K
a    
molar association constant  
K
d    
molar dissociation constant  
LB    Luria Bertani bacterial growth medium  
m   magnetic quantum number 
Mz,eq   longitudinal magnetization 
Mx,y   transvers magnetization 
mPTS   peroxisomal membrane protein targeting signal  
Ni-NTA   nickel nitrilotriacetic acid  
NMR    nuclear magnetic resonance spectroscopy  
NOE   nuclear Overhauser effect 
NOESY  nuclear Overhauser and exchange spectroscopy 
PAH2   paired amphipathic helix (domain) 2 
PBD    peroxisomal biogenesis disorder  
PCR    polymerase chain reaction  
PEX    gene encoding peroxin or Pex protein  
 7
Pex5p(L)   peroxin 5 protein, long isoform containing 37 extra residues (1-639)  
PMP    peroxisomal membrane protein  
ppm   parts per million 
PTS1    peroxisomal targeting signal type 1  
PTS2    peroxisomal targeting signal type 2  
R    gas constant, 8.314 J/mol/K  
RDC   residual dipolar coupling 
RING    really interesting new gene (zinc binding proteins)  
RNA   Ribonucleic acid 
S.cerevisiae, Sc Saccharomyces cerevisiae 
SCP2    sterol carrier protein 2, PTS1 containing protein  
SDS-PAGE   sodium dodecyl sulphate polyacrylamide gel electrophoresis  
SH3   type three Src homology domain  
SRP    signal recognition particle  
TAE    tris acetic acid / ethylenediaminetetraacetic acid 
TEV    tobacco etch virus protease  
TOCSY  total correlation spectroscopy  
TPR    tetratricopeptide repeat motif  
Tris    tris(hydroxymethyl)aminomethane 
UV    ultra-violet light  
WD-40 short ~40 amino acid motifs, often terminating in Trp-Asp (W-D)  
Y. lipolytica, Yl Yarrowia lipolytica 
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1 Introduction 
 
1.1   Peroxisomes 
 
Peroxisomes are ubiquitious, eukaryotic cell organelles surrounded by a simple lipid-bilayer 
and varying in size, number and protein composition depending on cell type and species. 
Peroxisomes were named by de Duve and Baudhuin (1966) for the hydrogen peroxide which 
is accumulated during many of the metabolic processes inside peroxisomes and then degraded 
by the enzyme catalase. Beside the hydrogen peroxide respiration there are two other 
generally conserved functions of peroxisomes: β-oxidation of fatty acids and response to 
oxidative stress. A large variety of other metabolic processes have been described. This 
includes the glyoxylate cycle in fungal and plant glyoxysomes, photorespiration in plant leaf 
peroxisomes or methanol and amino oxidation in yeast. In mammals peroxisomes contribute 
to ether phospholipid and cholesterol biosynthesis, phytanic acid α-oxidation or xenobiotic 
detoxification (reviewed by Brown and Baker, 2003; Eckert and Erdmann, 2003; Purdue and 
Lazarow, 2001a). Although mammal mitochondria are capable of carrying out β-oxidation of 
fatty acids, very long chain fatty acids and other substrates inaccessible to the mitochondrial 
enzyme machinery are shortened by peroxisomal β-oxidation enzymes (reviewed by Clayton, 
2001; reviewed by Wanders et al., 2001).  
 
 
Fig1.1: Peroxisomes. Cells which were grown with glucose as carbon source contain a few small 
peroxisomes (a), whereas cells that were grown with methanol in the medium are filled with large 
peroxisomes which may take up more than 80% of the entire cell volume (b) (Erdmann and Schliebs, 
2005) 
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1.2   Peroxisomal diseases 
 
Several inherited diseases caused by impaired peroxisomal function have been identified so 
far. They can be categorized into two main classes; one is characterized by malfunction of a 
single peroxisomal enzyme, the other by defects in peroxisomal biogenesis. Examples for 
class one are Acyl CoA oxidase deficiency or X-linked adrenoleukodystrophy.  
Class two can be divided into two subclasses. One subclass is characterized by loss of 
multiple peroxisomal functions normally caused by mutation of a single PEX gene. For 
example rhizomelic chondrodysplasia is caused by mutation of PEX7. The second subclass of 
peroxisomal biogenesis diseases is caused by mutations in multiple PEX genes und results in 
a general loss of peroxisomal function. These diseases, such as Zellwegers syndrome, 
neonatal adrenoleukodystrophy and infantile Refsum disease, differ in severity and patients 
survivability ranges from less than one year (Zellwegers syndrome) up to thirty years 
(infantile Refsum disease) (reviewed by Weller et al., 2003) 
 
 
1.3   Identification of peroxins 
 
Genetic complementation of yeast strains unable to grow on carbon sources that require 
functional peroxisomes for their metabolites, has led to the classification of the so called onu 
mutations (oleat non utilizers) which can be divided into two subgroups, the fox mutants (fatty 
acid oxidation) with defects in enzymes of the β-oxidation of fatty acids and the pex 
mutations (peroxisomal assembly) which are described by mislocalization of peroxisomal 
membrane or matrix proteins (Erdmann and Kunau, 1992; Erdmann et al., 1989). More 
recently, knock-out mouse models and RNA interference supplemented the complementation 
analysis and provided the tools for investigation of peroxisomal disorders in a disease context 
(Baumgart et al., 2003; Thieringer et al., 2003; Weller et al., 2003). So far 32 PEX genes and 
proteins derived of, called peroxins, were identified and categorized by localization and 
function (Table 1.1) 
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Table 1.1: Overview of peroxins identified to date 
(adapted from Eckert and Erdmann, 2003; Wagner et al., 2005) 
gene identified in proposed characteristics functions localization interacting 
peroxisomes 
 
 
 
 
   
PEX1 
 
AAA-protein required for peroxisomal 
matrix import 
mainly 
cytosolic 
6 
PEX2 
 
RING zinc finger protein, matrix protein 
import, receptor recycling 
iPMP* 10 
PEX3 PMP import, membrane biogenesis iPMP 19 
PEX4 
 
E2-ubiquitin conjugating enzyme pPMP** 22 
PEX5 
 
TPR-protein, PTS1 receptor mainly 
cytosolic 
7, 8, 10, 12, 
13, 14 
PEX6 AAA-protein, required for matrix protein 
import 
mainly 
cytosolic 
1, 15/26 
PEX7 WD-protein, PTS2 receptor mainly 
cytosolic 
5, 13, 14, 18, 
20, 21 
PEX8 matrix protein import luminal 5, 20 
PEX9 matrix protein import  iPMP  
PEX10 RING zinc finger protein, matrix protein 
import, receptor recycling 
iPMP 2, 5, 12, 19 
PEX11 peroxisome proliferation/ division  iPMP 19 
PEX12 RING zinc finger protein, matrix protein 
import, receptor recycling 
iPMP 5, 10, 19 
PEX13 SH3-protein, matrix protein import, 
receptor docking 
iPMP 5, 7, 14, 19 
PEX14 matrix protein import, receptor docking PMP 5, 7, 13, 17, 
19 
PEX15 membrane anchor, matrix protein import iPMP 6 
PEX16 PMP import iPMP 19 
PEX17 matrix protein import, receptor docking pPMP 14, 19 
PEX18 auxiliary protein, PTS2 import mainly 
cytosolic 
7 
PEX19 farnesylated, peroxisomal biogenesis, 
PMP receptor 
mainly 
cytosolic 
3, 10, 12, 13, 
14, 16, 17, 
11a/b 
PEX20 PTS2 matrix protein import mainly 
cytosolic 
 
PEX21 auxiliary protein, PTS2 import mainly 
cytosolic 
7, 13, 14 
PEX22 membrane anchor, matrix protein import iPMP 4 
PEX23 matrix protein import iPMP  
PEX24 peroxisomal proliferation and abundance iPMP  
PEX25 peroxisomal proliferation and abundance pPMP 27 
PEX26 membrane anchor, matrix protein import 
(human equivalent of Pex15p) 
iPMP 6 
PEX27 peroxisomal proliferation and abundance pPMP 25 
PEX28 peroxisomal proliferation and abundance iPMP  
PEX29 peroxisomal proliferation and abundance iPMP  
PEX30 peroxisomal proliferation and abundance iPMP 28, 29,31, 32 
PEX31 peroxisomal proliferation and abundance iPMP 28, 29,30, 32 
PEX32 
 
yeasts mammals plants Other 
 
 
+ + + 
 
Dm 
+ 
 
+ +  
+ + +  
+ + +  
 
+ + + Dm, Cl, Ld, 
Tb  
+ + + Cl 
 
+ + +  
 
+    
+    
+ + +  
 
+ + + Cl, Tb 
+ + + Cl 
 
+ + + Cl 
 
+ + +  
 
+    
+ + +  
+  +  
+    
 
+ + + Cl 
 
 
+    
 
+    
 
+    
+    
+    
+    
 +   
 
+    
+    
+    
+    
+    
+    
  
peroxisomal proliferation and abundance iPMP 28, 29,30, 31 
*iPMP: integral peroxisomal membrane protein; **pPMP: peripheral peroxisomal membrane protein 
Cl = Caenorhabditis. elegans; Dm = Drosophila melanogaster; Tb = Trypanosoma brucei 
 
 
 
 
 
 11
                                                                                                                                                Introduction 
 
 
1.4   Peroxisomal Biogenesis and the role of Pex19p 
 
Upon the first biological and biochemical characterization of peroxisomes two different 
models for peroxisomal biogenesis were proposed. While De Duve and Baudhin ((1966)) 
discussed the possibility of peroxisomes as autonomous organelles evolved from an 
endosymbiont, already 1964 Novikoff and Shin proposed the possibility of peroxisomes 
budding from the endoplasmatic reticulum. Lazarow and Fujiki (1985) described an ER-
independed “growth and division” model, which excluded de novo synthesis and suggested 
peroxisomes proliferation exclusively by division of pre-existing ones. South and Gould 
(1999) proposed two overlapping pathways, one based on the division of mature peroxisomes 
mediated by Pex11p and the other on the conversion of pre-existing  proto-peroxisomes by 
Pex16p. More recently, evidence supporting the ER as the origin of peroxisomes is rising 
(reviewed by Tabak et al., 2003; Titorenko and Rachubinski, 1998). Geuze at al. (2003) 
showed that the peroxisomal membrane proteins Pex13p and PMP70 could be found in 
subdomains of the ER continuous with peroxisomes. Hoepfner et al. (2005) demonstrated that 
the insertion of Pex3p into the ER and the recruitment of Pex19p lead to formation of 
peroxisomal membrane vesicles, giving rise to the assumption that peroxisomes receive their 
membrane exclusively from this organelle. In this new model (reviewed by Kunau, 2005), 
Pex3p and Pex19p, possibly under assistance of Pex11p and the dynamin-like protein Vps1p 
(Hoepfner et al., 2001), trigger the budding of a peroxisomal membrane from the ER. 
Peroxisomal membrane proteins (PMPs) are imported and, as soon as the translocation 
machinery is established, the peroxisome is filled with matrix proteins. Pex19p plays a major 
role in the import of PMPs and has been proposed as a cycling receptor for proteins carrying 
an mPTS (a targeting signal for peroxisomal membrane proteins) and/or, in complex with 
Pex3p, as a regulator for insertion and assembly of PMPs at the peroxisomal membrane. 
Apart from its function as receptor and regulator, Pex19p it has been described as a chaperone 
for newly synthesized PMPs in the cytosol (reviewed by Schliebs and Kunau, 2004).  
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1.5   Peroxisomal Protein Import 
 
1.5.1  Targeting sequences 
 
The import of cytosolic synthesized proteins into cell organelles requires the presence of 
special targeting sequences (Blobel and Dobberstein, 1975). Peroxins are synthesized at free 
ribosomes and posttranslationally imported into peroxisomes. During this process two 
peroxisomal targeting signals (PTS) play a crucial role. The vast majority of peroxisomal 
matrix proteins contain a PTS1, which consists of a C-terminal tripeptide with the consensus 
sequence (S/A/C)-(K/R/H)-L. The PTS2 sequence consists of an N-terminal nonapeptide with 
the consensus (R/K)(L/I/V)X5(H/Q)(L/A) (de Hoop and Ab, 1992) and is less common 
compared to PTS1. Furthermore proteins lacking a peroxisomal targeting sequence can be 
imported “piggyback” by PTS1 or PTS2 proteins (Glover et al., 1994; McNew and Goodman, 
1994).  
 
 
1.5.2   PTS-receptors and import models 
 
The PTS sequences are recognized by two different proteins, the PTS1 receptor Pex5p and the 
PTS2 receptor Pex7p. The C-terminus of Pex5p consists of 7 tetratricopeptide repeats (TPR) 
and a C-terminal helix bundle which together form a ring like structure upon ligand 
binding(Gatto et al., 2000; Stanley et al., 2006). No structural data is available for the PTS2 
receptor, but homology prediction characterizes Pex7p as a member of the family of WD40 
proteins which adopt a β-propellar structure (Purdue et al., 1997; Rehling et al., 1996). While 
Pex5p is capable to direct its cargo to the peroxisomal membrane on its own, Pex7p requires 
the assistance of auxiliary proteins, such as Pex18p and Pex21p in S.cerevisiae, Pex20p in Y. 
lipolytica or a long isoform of Pex5p in mammals (Einwachter et al., 2001; Purdue et al., 
1998; Schafer et al., 2004; Titorenko et al., 1998).  
To explain the different localization of the receptors, which could be detected in the cytosol, 
at the peroxisomal membrane and in the peroxisomal lumen, several models have evolved 
during the years. All of them have four steps in common: cargo recognition in the cytosol by a 
PTS-receptor, docking to the peroxisomal membrane, dissociation of the receptor-cargo-
complex and recycling of the receptor. (Fig. 1.5) 
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Fig 1.5: The four steps of PTS1 import. 
Cargo recognition, docking, dissociation 
and receptor recycling 
 
 
A first approach to explain the processes involved in peroxisomal protein import was the 
“simple shuttle” model. The receptor transports the cargo to the membrane, releases the cargo 
to the translocation machinery and travels back to the cytosol (Marzioch et al., 1994). The 
original model was expanded to the “extended shuttle” theory, where the receptor together 
with the cargo is translocated over the membrane and enters the peroxisomal lumen 
(Rachubinski and Subramani, 1995). This hypothesis was supported by studies of Dammai et 
al. (2001), who could demonstrate that at least parts of the PTS1-receptor Pex5p are exposed 
to the peroxisomal matrix. The latest model of peroxisomal protein import is the “transient 
pore” model (Erdmann and Schliebs, 2005), which combines the ability of Pex5p to integrate 
into peroxisomal membranes (Oliveira et al., 2003) and its ubiquitination (Kiel et al., 2005; 
Kragt et al., 2005) with the existing shuttle models. It describes Pex5p as the key component 
of a transient pore that is characterized by a high flexibility in size, formation and 
disassembly.  
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1.5.3   Membrane bound components of the peroxisomal import   
 machinery 
 
In addition to the presence of PTS receptors, all models implicate the involvement of other 
components in the process of translocation through the peroxisomal membrane. The integral 
membrane protein Pex13p, Pex14p and, in yeast, the Pex14p-associated Pex17p (Huhse et al., 
1998), were proposed as components of the docking complex (reviewed by Erdmann and 
Schliebs, 2005). Pex14p is essential for the import of peroxisomal matrix proteins and binds 
to the PTS-receptors Pex5p and Pex7p (Albertini et al., 1997). Pex14p deletion mutants exert 
defect in both import ways (Girzalsky et al., 1999). Pex13p also interacts with both PTS-
receptors and with Pex14p (Elgersma et al., 1996; Erdmann and Blobel, 1996; Girzalsky et 
al., 1999) implicating a role in the docking process.  
The RING (really interesting new gene) finger PMPs, Pex2p, Pex10p and Pex12p are widely 
thought to act downstream of receptor docking and are possibly involved in translocation of 
Pex5p or recycling of the PTS1 receptor via ubiquitination (reviewed by Erdmann and 
Schliebs, 2005; reviewed by Gould and Collins, 2002). Agne et al. (2003) have demonstrated 
that, in S.cerevisiae the docking proteins are linked with the RING finger complex within the 
peroxisomal matrix by the membrane associated protein Pex8p. So far, no Pex8p could be 
identified in mammals. 
Epistasis analysis suggest a role of the peroxins Pex4p and Pex22p as well as Pex1p and 
Pex6p, downstream of the RING finger proteins (Collins et al., 2000). Pex4p, an E2 ubiquitin 
conjungating enzyme (Wiebel and Kunau, 1992), is anchored to the cytosolic site of the 
peroxisomal membrane via Pex22p. Together with the Pex2/10/12p complex - the RING 
finger motif is a common domain of E3 ubiquitin ligases (reviewed by Pickart, 2001). These 
proteins are thought to be involved in ubiquitination of Pex5p and receptor recycling 
(reviewed by Erdmann and Schliebs, 2005; reviewed by Purdue and Lazarow, 2001b). The 
peroxins Pex1p and Pex6p belong to the family of AAA-proteins (ATPase associated with 
various cellular activities) and interact physically as well as functionally. They are associated 
with the peroxisomal membrane via Pex15p in yeast or its orthologue Pex26p in mammals. 
The AAA complex has been proposed to play a role in an energy depending dislocation of the 
PTS1-receptor from the peroxisomal membrane (Erdmann and Schliebs, 2005; Gould and 
Collins, 2002).  
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Fig. 1: The transient pore model (adopted from Erdmann & Schliebs, 2005) 
Pex5p recognizes the PTS1 protein in the cytosol and transports the cargo to the peroxisomal 
membrane. It inserts into the peroxisomal membrane and becomes an integral part of the import 
machinery. The docking proteins Pex14 and Pex13p (and in yeast Pex17p) are possibly involved in 
tethering the receptor to the membrane and in assembly, stabilization and rearrangement of the 
translocon. Cargo release is suggested to be triggered by Pex8p which contains a PTS1 sequence. 
Recycling and disassembly is thought to be ATP depended and requires the AAA+ peroxins Pex1p 
and Pex6p which are anchored to the peroxisomal membrane by Pex15p (or the human orthologue 
Pex26p). The disassembly and recycling process could be regulated by ubiquitination, possibly 
carried out by Pex4p an E3 type conjugation enzyme and the RING finger peroxins Pex2p, Pex10p 
and Pex12p. In this case monoubiquitination would lead to receptor recycling, polyubiquitination to 
degradation. 
 
1.6   The peroxin Pex14p and its ligands 
 
Pex14p, as mentioned above, is thought to be part of the peroxisomal docking complex and 
one of the initial contact points for the PTS receptors. Depending on the organism it has been 
described to be an integral membrane protein or as membrane associated via a hydrophobic 
region (Albertini et al., 1997; Will et al., 1999). Pex14p contains at least one coiled-coil 
region, which allows the formation of homo-dimers (Oliveira et al., 2002). It has been 
suggested that in the hydrophobic domain of human Pex14p, two interaction motifs (AxxxA 
and GxxxG) together with the coiled-coil domain are responsible for homo-oligomerization of 
Pex14p (Itoh and Fujiki, 2006). The N-terminus of Pex14p is well conserved among species 
and interacts with the PTS1 receptor Pex5p, another component of the docking complex, 
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Pex13p, and with the multifunctional protein Pex19p (Albertini et al., 1997; Brocard et al., 
1997; Sacksteder et al., 2000). The Pex14p-Pex5p interaction is mediated by a di-aromatic 
pentapeptide sequence motif (WxxxF/Y) in the N-terminal half of Pex5p (Schliebs et al., 
1999). A second Pex5p binding site, independent of the WxxxF/Y motif, and a binding site 
for the PTS2-receptor Pex7p have been reported to be present at the C-terminus of 
S.cerevisiae Pex14p (Niederhoff et al., 2005; Williams et al., 2005).  
Pex13p has been described as an integral membrane protein with two transmembrane domains 
and a cytosolic N- and C-terminus (Erdmann et al., 1996). The N-terminal half of Pex13p 
interacts with the PTS-receptors Pex5p and Pex7p, the C-terminal half contains a type three 
Src homology (SH3) domain and interacts with Pex14p (Fransen et al., 1998; Otera et al., 
2002). An additional intraperoxisomal Pex14p-binding site has been reported in yeast (Schell-
Steven et al., 2005). Douangamath et al. (2002) showed that the ScPex13p SH3 domain binds 
two distinct epitopes simultaneously. While the interaction with ScPex14p is mediated by a 
classical type two PxxP motif, ScPex5p binds ScPex13p via a non-classical WxxxF/Y motif, 
which displays no Pex14p binding (Williams et al., 2005). In humans, the homologous 
WxxxF/Y motif responsible for Pex13p interaction shows no Pex14p binding (Saidowsky et 
al., 2001). The interaction of S.cerevisiae Pex5p with Pex14p was reported to be mediated by 
an inverse WxxxF/Y (Williams et al., 2005). Human Pex5p contains five WxxxF/Y motifs 
(the long isoform of Pex5p contains an additional one) in its N-terminal half, which are able 
to bind Pex14p in vitro (Saidowsky et al., 2001). The reason for this multiplicity has not yet 
been fully explained. In vivo data about the stoichiometry of the mammalian Pex14p-Pex5p 
complex is contradictory, the described stoichiometries reach from 1 to 1(Itoh and Fujiki, 
2006) to 5 to1 (Gouveia et al., 2000), and an exact quantitative determination still remains to 
be carried out..  
Fransen et al (2005) were able to specify a region in the N-terminus of Pex19p that contains 
several aromatic residues. This non-classical WxxxF/Y motif interacts with the same 
conserved N-terminal domain present in Pex14p as Pex5p and Pex13p (Fransen et al., 2004). 
While Pex14p can bind Pex19p and Pex13p simultaneously, no complex of Pex14p, Pex5p 
and Pex19p has been reported (Itoh and Fujiki, 2006).  
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Fig 1.6: Domain composition of human Pex14p, Pex5p(L) and Pex19p. Pex14p contains a conserved 
N-terminal domain (aa 23-73), a hydrophobic region (aa 110-138) and a predicted coiled coil region (aa 
157-197). Depending on the prediction algorithm an additional coiled-coil domain in the C-terminus is 
proposed. The N-terminal domain interacts with Pex13p, Pex5p and Pex19p. The N-terminus of Pex14p 
contains several non canonical PxxP motifs (aa 7-13, 21-27, 85-91, 86-92, 95-101). Pex5p(L) has seven 
WxxxF/Y motifs (W1 118-122; W2 140-144; W3 159-163; W4 184-188); W5 243-247; W6 257-261; 
W7 308-312), whereas W4 overlaps with the Pex13p binding site (aa 184-192) and does not interact 
with Pex14p. A stretch of 37 amino acids (aa 215-251) allows the long isoform of Pex5p to interact 
with Pex7p (aa 192-222). PTS1 cargo recognition is carried out by the C-terminal TPR domains (aa 
335-589). Pex13p contains two transmembrane regions (aa 136-158 and aa 227-251) and a C-terminal 
SH3 domain. The N-terminus of Pex13p interacts with Pex5p and Pex7p. Pex19p shows two Pex3p 
binding sites, an N-terminal one (aa 1-51) and one overlapping with the interaction site of peroxisomal 
membrane proteins. Pex14p-Pex19p interaction is mediated by an aromate-rich motif (aa 66-77). A C-
terminal CAAX-motif of Pex19p is responsible for farnesylation of the protein. 
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1.7   Objectives of this thesis 
 
One of the major implications of proteins lies in their ability to interact with each other via 
specific binding. This directed association of peptide or protein molecules can be transient or 
permanent and is determined by the individual biochemical and biophysical properties of the 
interaction partners. To describe the mechanism of how proteins are able to discriminate 
among the multiplicity of possible interaction partners is certainly one of the major tasks in 
structural biology. The N-terminus of Pex14p constitutes the point of convergence of at least 
three different interaction partners and provides therefore an excellent target for studies of 
protein-protein interactions. The focus of this work laid on determination of a high resolution 
structure of N-terminal Pex14p and one of its ligand. Special attention was directed to the 
interaction of Pex14p with the PTS1 receptor Pex5p as well as the multifunctional protein 
Pex19p and the molecular details of interaction, i.e. how does the conserved WxxxF/Y of 
Pex5p mediate the binding? Is the binding of Pex19p and Pex5p competitive? Which protein 
is the stronger ligand? How does Pex19p bind Pex14p without a WxxxF/Y motif?  
The initial approach to address these questions was X-ray crystallography. As a prerequisite 
to this method large scale protein purification and in vitro complex formation of N-Pex14p 
and its ligands needed to be established. However, when it became apparent that 
crystallization trails continued to fail, the method was changed to NMR spectroscopy. This 
provided the opportunity not only to determine the structure of complexed Pex14p but also 
allowed an estimation of the structural character of the free components and the structural 
changes induced upon ligand binding by secondary chemical shift analysis and NMR 
relaxation experiments. To investigate the competitive character of the Pex14p-Pex5p and –
Pex19p interaction NMR titration experiments were carried out. The NMR data was 
supplement and quantified by isothermal titration calorimetry experiments  
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2 Materials and Methods 
 
 
2.1   Materials 
 
Chemicals were bought at the highest available purity from Sigma unless state otherwise. 
15NH4Cl, [U-13C]-glucose and D2O were purchased from Spectral Isotopes. DNA 
oligonucleotide primers were purchased from MWG (Germany).  Peptides were synthesized 
by Dr. Wolfgang Nastainczyk (Medizinische Biochemie und Molekularbiologie, Universität 
des Saarlandes) 
 
2.1.1   Bacterial strains 
 
 
Strain Genotype 
E. coli DH5α F-, lacI-, recA1, endA1, hsdR17, Δ(lacZYA-argF),   U169, 
F80dlacZΔM15, supE44, thi-1, gyrA96, relA1 
E. coli 
BL21(DE3)PlysS 
B, F-, dcm, ompT, hsdS(rB-mB-), gal, λ(DE3), pLysS Cam 
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2.1.2   Commonly used buffers and media 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibiotics (1000x stock solutions) 
Ampicilin 100mg/ml H2O 
Kanamycin 50mg/ml H2O 
Chloramphenicol 34mg/ml Ethanol 
 
Coomassie staining solution 
SDS-PAGE running buffer 
0.1M Tris 
0.1M Tricine 
0.1% SDS 
 
0.1M Sodium phosphate buffer pH 6.5 
68.5% 0.1M NaH2PO4 solution 
31.5% 0.1M Na2HPO4 solution 
 
4M Sodium chloride 
233.77g NaCl 
ad  1 liter MilliQ H2O 
 
1M Tris/HCl 
0.01% (w/v) Brilliant Blue R 
10% acetic acid 
 
Coomassie de-staining solution 
10% acetic acid 
20% Ethanol 
 
DNA-Gel Sample buffer, 10ml 
6ml Glycerol 
60mM EDTA 
121.13g Tris base 
ad 1 liter MilliHQ H2O 
9g Bromphenol blue  
SDS-PAGE Sample buffer 
50mM Tris/HCl, pH 8.0 
2% (w/v) SDS 
9g Xylene Cyanol FF 
 
Luria-Bertani (LB) medium 
10g tryptone 
5g yeast extract 
10% (v/v) Glycerol 
1% (v/v) b-ME 
12.5mM EDTA 
0.02% Bromphenol blue 
10g NaCl 
(15g agar for plates) 
ad 1 liter MilliQ H2O  
TAE 
40mM Tris-acetate 
 
 
2mM EDTA  
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2.2  Methods 
 
 
2.2.1   Plasmid construction 
 
The following plasmids were kindly provided by our collaborators Wolfgang Schliebs and 
Marc Fransen 
 
Table 3.1: Provided plasmids 
Vector Manufacturer Insert Provided by 
pET9d Novagen Pex5p long full length W. Schliebs 
pET9d Novagen Pex5p aa 115-335 W. Schliebs 
pET9d Novagen Pex5p aa 1-115 W. Schliebs 
pGEX4T-3 Amersham Pex14p full length M. Fransen 
pQE30 Quiagen Pex13p full length M. Fransen 
pETM-30/11 EMBL, G.Stier Pex19p aa 1-124 M. Fransen 
pETM-30/11 EMBL, G.Stier Pex19p aa 51-124 M. Fransen 
 
 
Full length Pex14p (GenBank accession. No. AF045186), Pex13p (GenBank accession. No. 
AF048755) and Pex5pL (GenBank accession. No. Z66494) served as a template for the 
different constructs listed below (Table 2.2) 
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Table 2.2: Constructs created in this thesis 
Insert 
Pex14p aa 1-80W 
Pex14p aa 1-78 
Pex14p aa 16-78 
Pex14p aa 16-80W 
Pex14p aa 23-78 
Pex14p aa 23-80W 
Pex5p(L) aa 214-335 
Pex13p aa 271-344 
Pex5p aa 214-639 
Pex5p aa 303-639 
All constructs were cloned into a pETM-11 or pETM-30 vector via an NcoI/NotI site 
 
All primers were designed for an annealing temperature of 65°C and with overhangs for the 
designated restriction enzymes. PCR reactions were performed according to the manufactures 
manual using KOD DNA Polymerase (Novagen, Germany) 
PCR products, purified via the QIAquick PCR Purification Kit (Quiagen, Germany), and the 
desired vector were digested with NcoI and NotI in 50 µl reactions at 37°C overnight using 
Buffer No 3 (New England Biolabs, USA). The cleaved DNA was separated by agarose gel 
electrophoresis (between 0.8 and 1.5% agarose in TAE supplement with 25 µg ethidium 
bromide per 50 ml). The DNA bands were excised under UV light from the gel and isolated 
via the QIAquick Gel Extraction Kit (Quiagen, Germany). 
Plasmid and insert were mixed in an approximate 1:5 ratio and incubated with 1 µl T4 DNA 
for 1 h at 16°C. The whole 10 µl reaction mix was used for transformation into DMSO 
competent DH5α E.coli cells and plated out on LB plates containing the respective antibiotic.  
Single colonies were picked and proliferated. Plasmid DNA was isolated using a Miniprep Kit 
(QIAprep Spin, Quiagen, Germany). All created constructs were analyzed by restriction 
enzyme digestion and sequenced by MWG (Germany) 
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Table 2.3: List of oligonucleotides used 
Primer Sequence (5’ ? 3’) 
14-1for CATGCCATGGCGTCCTCGGAGCAG 
14-80Wrev ATAGTTTAGCGGCCGCTTACCACAAGGACGAAGGCTCATCG 
14-16for CATGCCCATGGCGACTCCAGGAAGTGAAAATGTG 
14-78rev ATAGTTTAGCGGCCGCTTTCCACCGAAATTCCT 
14-23for CATGCCCATGGCCTGAGAGCCGCTGATTGCCACGGC 
13-271for CATGCCATGGAGGATGACCATGTAGTTGC 
13-344rev TCCGAGCTCGCGGCCGTTAATTCCACCGTTTTCCTACCTTT 
5-264for CATGCCATGGAGGCCCACCCCTGGCT 
5-639rev   TCCGAGCTCGCGGCCGTTACTGGGGCAGGCCAAACATAG 
5-238for    CATGCCATGGCTCAGGCAGAACAGTG 
5-267rev   TCCGAGCTCGCGGCCGTTAGATGTGTTTACTGGTCTTGT 
5- 214for CATGCCATGGTGTCTGAGTTCCTGAAATTCGTGCGGC 
5- 335rev TCCGAGCTCGCGGCCGCTAGTGATCACGCAAGGGGTTC 
The first number specifies the peroxin, the second number the DNA base; for = forward/sense, rev = 
reverse/antisense 
 
 
 
 
2.2.2   Expression and purification of His6-tagged proteins 
 
His6-tagged proteins were expressed in a BL21(DE3) pLysS E.coli strain. Cells were grown 
in LB medium containing the respective antibiotics at 37°C until OD600 of 0.6 was reached. 
The temperature was lowered to 30°C and the culture induced with 0.5 mM IPTG per liter for 
additional 3 hours. Cells were harvested by centrifugation, frozen and stored at -20°C. 
For purification, pellets were resuspended in Lysis buffer supplemented with protease 
inhibitors (Complete Mini EDTA-free Tablets, Roche, Germany). Cell walls were disrupted 
via sonication (HD2200 generator, Bandelin Electronic, Germany). The cell extract was 
centrifuged at 45000xg (1h, 4°C, rotor SS34, Sorvall RC5B). The supernatant was applied to 
Ni-NTA Agarose. The resin was added to a disposable column (Quiagen, Germany), washed 
with 8 column volumes wash buffer and eluted with 3 column volumes elution buffer. Buffer 
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was exchange to cleavage buffer via a PD-10 desalting column (GE Healthcare, Europe).  
After overnight incubation with His6 fused TEV-protease (ratio protein:protease 50:1) at room 
temperature a second Ni-NTA column removed uncleaved protein, the His6 fusion tag and the 
protease. The flow through was concentrated and analyzed by SDS-PAGE using 10% Tris-
glycine gels or 10-20% Tris-Tricine gels, followed by Coomassie staining.  
 
Lysis buffer       Wash buffer 
30mM Tris/HCl, pH 8    30mM Tris/HCl, pH 8 
300mM NaCl      500mM NaCl 
10mM Imidazol     25mM Imidazol 
5mM, β-ME      5mM β-ME 
 
Elution buffer      Cleavage buffer 
30mM Tris/HCl, pH 8    30mM Tris/HCl, pH 8 
150mM NaCl      150mM NaCl 
400mM Imidazol     10mM Imidazol 
5mM, β-ME      5mM, β-ME 
 
To take account of the different biochemical properties the protocol was modified for the 
following proteins: 
 
 
• Pex14p (aa 16-80W and aa 16-78)  
The lysis and wash buffer contained 500mM NaCl. Buffer exchange and TEV cleavage was 
performed by overnight dialysis against cleavage buffer with the protease added to the eluat. 
 
• Pex5p (all constructs) 
The main culture was induced overnight with 0.5mM IPTG per liter at 22°C.  
All purification steps were performed at 4°C with ice cold buffer. TEV cleavage was 
performed at room temperature for 5 hours.  
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2.2.3   Expression and Purification of isotopically labelled proteins 
 
Isotopically labelled proteins were prepared by growing E.coli BL21(DE3) pLysS cells in 
minimal medium supplemented with either [U-13C]-Glucose and/or 15NH4Cl and the 
respective antibiotics at 37°C. After overnight induction with 0.5mM IPTG per liter culture at 
25°C cells were harvested by centrifugation. Sample purification was conducted as described 
in 2.2.2. Proteins or protein complexes were exchanged into 50mM potassium phosphate with 
100mM NaCl (pH 6.5) by gel filtration (paragraph 2.2.4) 
 
 
 
100x trace elements stock solution  
5g EDTA, pH 7.5 
0.83g FeCl3*6H2O 
84mg ZnCl2 
13mg CuCl2*2H2O 
10mg CoCl2*6H2O 
13mg CuCl2*2H2O 
10mg CoCl2*6H2O 
10mg H3BO3 
1.6mg MnCl2*6H2O 
were dissolved in 1 liter Milli-Q water 
and sterile filtered (0.22µm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M9 minimal medium 
6g Na2HPO4 
3g KH2PO4 
0.5g NaCl 
0.5g 15NH4Cl (Spectra Stable Isotopes) 
4g Glucose or 2g [U-13C]-Glucose 
1ml 1M MgSO4 
0.3ml 1M CaCl2 
1mg Biotin 
1mg Thiamin 
10ml 100x trace elements stock solution 
were dissolved in liter Milli-Q water and 
sterile filtered (0.22µm) 
 
 
2.2.4   Ion exchange and size-exclusion chromatography 
 
Single proteins and complexes with equal ratios of the complex components were further 
purified by gelfiltration. Protein complexes were formed by mixing the single components in 
the desired stoichiometry followed by 15 min incubation on ice. Size-exclusion 
chromatography was performed on an Äkta Purifier or Äkta Explorer (GE Healthcare, 
Europe) at 4°C via a Superdex 200 or Superdex 75 column (GE Healthcare, Europe) in either 
Buffer A or B as running buffer 
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Buffer A (Crystallization Buffer) 
20mM BisTrisPropane, pH 7.5 
150mM NaCl 
1 mM DTT 
Buffer B (ITC/NMR Buffer) 
100mM NaCl 
50mM Potassium phosphate, pH 6.5
Prior to gelfiltration, Pex5p constructs were purified by ion-exchange chromatography 
(HiTrap Q, GE Healthcare, Europe) using a salt gradient (50mM NaCl to 600mM NaCl, 
25mM Tris/HCl pH 8, 5mM β-ME; gradient length 20 column volumns) 
 
 
2.2.5   Determination of protein concentration 
 
Protein samples were diluted 1:20 in 6M guanidinium hydrochloride buffered in 50mM 
potassium phosphate (pH 6.5). Absorption was measured at 280 nm and concentration was 
determined according to Beer-Lambert law 
lcA ⋅⋅= 280280 ε  
the extinction coefficient ε280  was calculated by the program Protparam 
(www.expasy.org/tools/protparam.html), the path length l was 1cm 
 
 
2.2.6   Dynamic light scattering 
 
Measurements were conducted on a Dyna Pro 99 device (Wyatt Tech. Corp., USA). At least 
20 data points of a 25 µl sample were recorded. 
 
2.2.7   Crystallization strategies  
 
Gelfiltrated N-terminal Pex14p constructs or binary and ternary complexes were diluted with 
MilliQ water to decrease buffer and salt concentration to 10mM BTP pH 7.5 and 75mM 
NaCl. N-Pex14p-peptide complexes were established by mixing protein and dissolved 
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peptides in the appropriate ratio. Proteins were concentrated to 10, 15, 20, 25 or 35 mg/ml and 
applied to the following sparse matrix crystallization screens.  
 
Index Screen (Hampton Research, USA) 
Crystal Screen I (Hampton Research, USA) 
Crystal Screen II (Hampton Research, USA) 
Ammonium sulphate Grid Screen (Hampton Research, USA) 
PEG/Ion Screen(Hampton Research, USA) 
Crystal Screen Lite (Hampton Research, USA) 
Crystal Screen Cryo (Hampton Research, USA) 
SaltRX (Hampton Research, USA) 
Wizard I (Emerald BioStrucures, USA) 
Wizard II (Emerald BioStrucures, USA) 
Cryo I (Emerald BioStrucures, USA) 
Cryo II (Emerald BioStrucures, USA) 
 
Screens were set up by mixing 0.3 to1µl protein with reservoir solution in a 1:1 ratio on 96 
well sitting drop plates with 120 µl reservoir solution or on 24 well hanging drop plates with 
500µl reservoir solution. Screens were stored at 21°C and regularly inspected with a 
dissection microscope equipped with cross-polarizers. Promising conditions were tried to 
optimize by streak microseeding (Bergfors, 2003), additive screens (Cudney et al., 1994) 
and/or variations of pH and precipitant of the original condition. (McPherson, 1990)  
The X-ray diffraction properties of crystalloids were tested under the supervision of Petri 
Kursula (EMBL-Hamburg, Germany) on EMBL beamline X13 of the DORIS III storage ring 
at the Deutsche Elektronen Synchrotron, Hamburg. X13 is a bending magnet beamline, 
equipped with a 165mm MAR charge-coupled device detector, operated with MARCCD 
version 0.9.7 software (MAR Research GmbH, Germany) and Oxford Cryosystems (Oxford, 
UK) cooling. A description of the current beamline set-up can be found at http://www.embl-
hamburg.de/facilities/px_beamlines.html.  
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2.2.8   Exopeptidase assay 
 
0.5 mg/ml Pex14p (aa 1-80W)-Pex5p (aa 214-335) complex was digested with 0.1 mg/ml 
Aminopeptdiase in 100mM MES buffer pH 6.5 or Carboxypeptidase in 100mM HEPES 
buffer pH 7.0 supplemented with 100mM NaCl at 20°C overnight. The samples were checked 
on a SDS-Gel and send to mass spectrometry (Dr. Jens Pfannstiel, Universität Heidelberg) for 
analysis. 
 
 
2.2.9   Pull down assay 
 
Proteins were expressed in separately expressed in E.coli and purified as described in 
paragraphs 2.2.2 and 2.2.4. with the exception that the His6-tag of the bait protein was not 
cleaved of. The bait was mixed in 20 mM BTP, pH 7.5 150 mM NaCl with an excess of 
untagged interaction partner and bound to Ni2+-NTA beads by turning end over end at 4° for 
0.5h. The beads were centrifuged and washed 5 times. Complexes were eluted either by 
cleavage with His6-TEV protease or by boiling in SDS-sample buffer and analyzed by SDS-
PAGE. 
 
 
2.2.10 Isothermal titration microcalorimetry 
 
ITC measurements were conducted on a MicroCal VP-ITC using Pex14p (aa 16-80) at 35 µM 
as a sample and Pex5p or Pex19p peptide at 300-500 µM as the titration ligand. The reference 
cell was filled with degassed Milli-Q water containing 1% sodium azide. Proteins and ligands 
were co-dialyzed against 50mM potassium phosphate buffer (pH 6.5) with 100mM NaCl. All 
experiments were conducted at 298K at a stirring speed of 300rpm. Per experiment, 18 
subsequent injections of 10-12 µl were separated by 300s equilibration time. Ligand heats of 
dilution were subtracted and data was fitted using MicroCal Origin 7.0 with the standard 
model for a 1:1 stoichiometry complex based on the Wiseman isotherm (Turnbull and 
Daranas, 2003; Wiseman et al., 1989): 
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with the standard enthalpy oHΔ , the effective volume of the calorimeter cell  and the total 
concentration of the ligand [ . Equation 1 relates the stepwise change in heat of the system 
normalized with respect to moles of ligand added per injection (
0V
]tX
tXddQ ][ ) to the absolute 
ratio of ligand to receptor concentration ( [ ] [ ]ttR MXX /= ) at any point during the course of 
titration.   is the total protein concentration and r is defined by [ ]tM
[ ]ta MKr =
1      (2) 
where  is the association constant. Using the Helmholtz relationship  aK
STHKRTG a Δ−Δ=−=Δ ln  
where R is the gas constant (8.33 J/mol/K), T the temperature in Kelvin, the binding entropy 
 and the Gibbs free energy of binding, SΔ GΔ was calculated. The dissociation constant  
was calculated as the reciprocal of   (Leavitt and Freire, 2001) 
dK
aK
 
 
2.2.11 NMR Spectroscopy  
 
NMR spectra were acquired at 303K on a Bruker DRX500, DRX600 or DRX800 
spectrometer with cryogenic probes unless otherwise stated. Spectra were processed with 
NMRPipe (Delaglio et al., 1995) and analyzed using NMRVIEW (Johnson, 1994)  
 
 
2.2.11.1   Resonance assignments 
 
Backbone and side chain chemical shifts of Pex14p (aa 16-80W) in complex with the Pex5p 
ligand were obtained using standard triple resonance experiments namely HNCA, 
CBCA(CO)NH, HNCACB, (H)CCONH-TOCSY, -TOCSY and HCCH-TOCSY (Sattler, 
1999). Pex14p-Pex19p protein backbone and chemical shifts were transferred from the 
Pex14p-Pex5p complex and adapted. NOE restraints for NMR structure determination were 
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obtained from the following experiments (Table 3.4). All Pex14p-Pex19p complex spectra 
were recorded with a 2.5 fold excess of ligand.  
 
Table 2.4: List of NOE experiments 
Experiment Mixing time 
Pex14p-Pex5p/Pex14p-Pex19p 
Base frequency 
Pex14p-Pex5p/Pex14p-Pex19p 
2D NOESY, D2O 100/100;200 ms 800/800; 600 MHz 
3D 15N NOESY 120 ms 500/600 MHz 
2D 12C/14N-filtered NOESY , D2O 120 ms 500/600 MHz 
2D 12C/14N-filtered NOESY , H2O 120 ms 500/600 MHz 
3D 13C HMQC NOESY, D2O 120 ms 500 MHz 
3D13C-edited, 12C/14N-filtered 
NOESY, D2O 
150 ms 500 MHz 
 
 
2.2.11.2  Distance, torsion angle and orientational restraints 
 
Intramolecular NOE restraints were obtained from 2D and 3D spectra. Intermolecular NOEs 
were derived from X-filtered 2D and 3D experiments and used as structural constraints for the 
calculation of the protein-peptide complex (Gemmecker, 1992). HN-N RDCs were measured 
in a liquid crystalline medium (Otting et al., 2000). Protein backbone restraints were obtained 
from secondary chemical shifts and sequence homology by the programme TALOS 
(Cornilescu et al., 1999). Slow exchanging amide protons were identified from 1H,15N-HSQC 
experiments after dissolving the lyophilized sample in 2H2O and included in structure 
calculations as hydrogen bond restraints. 
 
2.2.11.3   Structure calculation and validation 
 
The experimentally determined distance, dihedral and dipolar coupling restraints (Table 1) 
were applied in a simulated annealing protocol using ARIA1.2 (Linge et al., 2001). 100 
structures were calculated in the final iteration of those the best 10 were refined in a shell of 
water molecules. Structural quality was analyzed and structural statistics were computed by 
ARIA1.2 and PROCHECK-NMR (Laskowski et al., 1996). Ring current shifts and r.m.s. 
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deviation of Pex14p-Pex5p and Pex14p-Pex19p complex structure were calculated by 
MOLMOL (Koradi et al., 1996). Protein-peptide interface area was calculated by NOC 
(http://noc.ibp.ac.cn/, according to (Richards, 1977)). 3-dimensional figures were prepared via 
PYMOL (DeLano, W.L.; http://www.pymol.org) 
 
 
2.2.11.4   Chemical shift perturbation and secondary chemical 
  shifts 
 
Chemical shift changes of backbone amide groups (Δδ) were monitored in two-dimensional 
1H, 15N-HSQC experiments and calculated with 
( ) 21521
5
1 ⎟⎠
⎞⎜⎝
⎛ Δ+Δ=Δ NH δδδ  
where and  are the changes of 1H and 15N chemical shift in ppm. H1δΔ N15δΔ
 
Secondary chemical shifts were calculated via NMRView, according to 
 
Δδ=δSα-δSβ = (δSα(obs)-δSα(rc))-(δSβ(obs)-δSβ(rc)) 
 
δSα and δSβ are the observed (obs) or random coil (rc) chemical alpha and beta shifts (i.e. Cα, 
Cβ, Hα, Hβ) (Wishart et al., 1995) 
Ring current shifts were accounted for Hα secondary chemical shift calculation of bound 
peptides. An average ring current shift was determined for the ten lowest energy complex 
structures. Only ring current shifts larger than 0.3 ppm were considered for calculation of the 
avarage value. The determined average ring current shift was subtracted from the secondary 
chemical shift value.  
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3 Results 
 
 
3.1   Constructs created in this thesis 
 
The following human Pex14p and ligand constructs (Fig. 3.1) were created as described in 
Materials and Methods paragraph 2.2.1. 
 
 
Fig. 3.1: Overview of Pex14p, Pex13p and Pex5p constructs for his work. For an overview of the 
complete domain composition see paragraph 1.6 
 
 
The Pex14p (aa 1-108) constructs represents the N-terminal part of the protein up to its 
hydrophobic region. It contains 5 non canonical PxxP motifs, the conserved N-terminal 
domain and the reported binding sites for Pex13p, Pex5p and Pex19p. The construct was used 
for interaction studies with the SH3 domain of Pex13p (see paragraph 3.5)  
Pex14p (aa 1-80W) was the initial N-terminal construct created in this work. The native 
protein fragment (Pex14p (aa 1-80)) contains no amino acid with an absorption maximum at 
280 nm, thus the additional, C-terminal tryptophan facilitates quantification and purification 
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(especially size-exclusion chromatography). NMR studies revealed no effect of the 
tryptophan on the binding properties or ternary structure of the protein (see paragraph 3.6). 
Additional N-terminal Pex14p constructs (Pex14p (aa 1-78); Pex14p (aa 16-80W); Pex14p 
(aa 16-78); Pex14p (aa 23-80W); Pex14p (aa 23-78) were designed according to the results of 
globularity prediction and exopeptidase assays (paragraph 3.2) and should facilitate 
crystallization (see paragraph 3.3).  
To test the interaction of N-terminal Pex14p with different ligands (see paragraph 3.4 and 
3.5), a construct containing the SH3 domain of Pex13p and three Pex5p constructs were 
cloned.  
 
 
3.2   Domain boundaries of human N-Pex14p 
 
Definition of domain boundaries of the N-terminal Pex14p as a target for structural studies 
was initially conducted by globular fold prediction. The program GLOBPLOT (Linding et al., 
2003) predicts the very N-terminus of Pex14p as disordered. The chosen propensity (Russel-
Linding) predicts the starting position of the structured N-terminal part for residue 23 (Fig. 
3.2). 
 
 
Fig. 3.2: Globularity prediction of 
hsPex14p by Globplot (Linding et al., 
2003). A downward trend indicates 
globularity, an upward trend disorder. 
The black line indicates the beginning of 
the structured N-terminal domain. 
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According to this prediction, two constructs Pex14p (aa 23-80W) and Pex14p (aa 23-78) were 
cloned. Although the expression was very well, the proteins were mainly insoluble and had a 
strong tendency to aggregate (data not shown).  
To obtain a soluble and structured N-terminal domain fragment of Pex14p an exopeptidase 
assay was performed (Material and Methods 2.2.8). A complex of His6-tev-Pex14p (aa 1-
80W) and His6-tev-Pex5p (aa 215-335) was incubated with aminopeptdiase M or 
carboxypeptidase Y at 20°C. The digested sample was flash frozen and sent to mass 
spectroscopy for analysis (see Appendix II 7.1). 
 
 
Fig. 3.3: Exopeptidase assay. A 
complex of His6-tev-Pex14p (aa 1-80W) 
and His6-tev-Pex5p (aa 215-335) was 
incubated with an N- and C-terminal 
exopeptidase.  (1) protein complex 
alone, (2) protein complex plus 
aminopeptdiase M, (3) protein complex 
plus carboxypeptidase Y, (4) 
aminopeptdiase M alone, (5) 
carboxypeptidase Y alone. 
 
 
Two different fragments, Pex14p (aa 3-80W) and Pex14p (aa 16-80W), could be identified in 
the N-terminal digestion. Interestingly no stable N-terminal Pex5p fragment was found, 
indicating a complete digestion of the protein. In the C-terminal sample His6-tev-Pex14p (aa 
1-78) and His6-tev-Pex5p (aa 215-334) could be detected. According to these results three 
new constructs, Pex14p (aa 1-78), Pex14p (aa 16-80W) and Pex14p (aa 16-78), were cloned. 
 
 
3.3   Expression, purification and crystallization of N-terminal Pex14p 
 
Pex14p (aa 1-80W), Pex14p (aa 1-78), Pex14p (aa 16-80W) or Pex14p (aa 16-78) was 
expressed in E.coli and purified via Ni-affinity chromatography. The buffer was exchanged 
and the protein digested with His6-TEV protease. The His6-tag and the protease were removed 
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by a second Ni-affinity step. The flow through was collected, concentrated and further 
purified by gelfiltration. Fig. 3.4 (A) and (B) show exemplarily the purification of Pex14p (aa 
16-80W). 
 
 
Fig. 3.4: (A) Purification of His6-tev-Pex14p (aa 16-80W). The protein was expressed in E.coli and 
purified by Ni-affinity chromatography. Total cell lysate (1), soluble (2) and unbound fractions (3), 
wash (4), elution (5) and the flow through after TEV cleavage (6) of the affinity column were 
separated by SDS-PAGE and analyzed by Coomassie staining. (B) Cleaved Pex14p (aa 16-80W) was 
subjected to size exclusion chromatography using a Superdex 75 column. The protein elutes as single 
peak. Fractions containing the purified protein were pooled, concentrated and used for crystallization 
trials or NMR studies. (C) Purity of N-terminal Pex14p constructs after gelfiltration. 
 
 
The protein containing fractions were pooled and concentrated to 10, 15 25 or 35mg. 
Monodispersity was checked by dynamic light scattering, only samples with values higher 
than 75% were used for crystallization. The proteins alone (Fig 3.4 (C)) or in complex with 
Pex5p peptide were applied to sparse matrix crystallization screens (Material and Method, 
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paragraph 2.2.7). Table 3.1 shows the different protein concentration and the protein/peptide 
ratio. 
 
Table 3.1: Overview of the N-Pex14p-Peptide complexes used for crystallization 
N-Pex14p Protein : peptide ratio 
Pex5p (aa 114-126)              Pex5p (116-124) 
 
Pex14p (aa 1-80W), 10 and 15 mg/ml 
 
1:0, 1:1, 1:1.5, 1:2                 1:1.5 
Pex14p (aa 1-80W), 25 mg/ml 1:0, 1:1 
Pex14p (aa 1-80W), 35 mg/ml 1:0 
Pex14p (aa 1-78), 10 and 20 mg/ml 1:0, 1:1 
Pex14p (aa 16-80W), 10 and 15 mg/ml 1:0, 1:1.5                                  1:1, 1:1.5, 1:2 
Pex14p (aa 16-80W), 20 mg/ml                                                  1:0, 1:1 
Pex14p (aa 16-78), 10 and 15 mg/ml                                                  1:0, 1:1 
 
 
Micro-crystals and “spherulites” were mainly found in conditions containing 0.5-2M 
ammonium sulphate, pH 5.5-7.5 or 15-25% PEG 3350, pH 5.5-8.0. Crystalloids were tested 
on EMBL beamline X13 of the DORIS III storage ring at the Deutsche Elektronen 
Synchrotron, Hamburg. So far, no diffraction pattern could be obtained. 
 
 
3.4   In vitro complex formation and crystallization of N-terminal Pex14p 
 and ligands 
 
N-Pex14p and the different ligand constructs were expressed separately in E.coli, purified and 
complexed in vitro (see paragraph 2.2.2 and 2.2.4). In addition to the constructs cloned in this 
thesis (see paragraph 3.1) constructs provided by our collaborators, i.e. Pex5p (aa 1-335), 
Pex5p (aa 115-335), Pex5p(L) and Pex19p (aa 1-124) (see Material and Methods 2.2.1) were 
used for in vitro complex formation and crystallization trials. 
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Fig. 3.5: Gelfiltration of N-terminal Pex14p complexes were carried out on a Superdex 200 or Superdex 
75 (dashed line) column 
 
 
All constructs showed an in vitro interaction with N-terminal Pex14p as demonstrated by 
size-exclusion chromatography. (Fig. 3.5). Beside the dimeric Pex14p-Pex5p or Pex14p-
Pex19p complex, complexes of N-terminal Pex14p, C-terminal Pex5p and the Pex5p-Cargo 
proteins mSCP2 or Luciferase could be established. Luciferase, a synonym for the enzyme 
luciferin 4-monooxygenase from north-american firefly, contains a PTS1 signal and is 
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commercially available (Sigma). Although such a complex is artificial, luciferase, introduced 
to mammalian cells, is targeted to peroxisomes (Keller et al., 1987). 
 
 
Fig. 3.6: Pull down assays of 
purified recombinant His6Pex5p(L), 
Luciferase and Pex14p (aa 1-80W) 
(A), His6Pex5p(L), mSCP2 and 
Pex14p (aa 1-80W) (B), Pex5p (aa 
214-335) and His6-tev-Pex14p (aa 
1-80W) (C) and His6-tev-Pex14p 
(1-108) and Pex5p (aa 214-335). 
Proteins were mixed and incubated 
with Ni-NTA beads. Samples of 
proteins in total (t), flow through 
(ft) wash (w), after TEV cleavage 
(c) or Ni-NTA beads (b) were 
separated by SDS-PAGE and 
analyzed by Coomassie staining. 
 
 
The in vitro interaction of N-terminal Pex14p with Pex5p (aa 214-335) as well as the 
formation of a ternary complex of N-terminal Pex14p, Pex5p(L) and mSCP2 could be 
confirmed by a pull down assay (Fig. 3.6).  
All complexes were applied to sparse matrix crystallization screens (Material and Methods 
2.2.7). So far, no crystals could be obtained. 
 
 
3.5   In vitro interaction tests of the Pex13p-SH3 domain and N-terminal 
 Pex14p constructs 
 
Human Pex13p has been described to interact with N-terminal Pex14p (Fransen et al., 2004; 
Itoh et al., 2006). In order to investigate if this interaction is mediated by the SH3 domain and 
non canonical PxxP motifs in Pex14p, different Pex14p constructs were tested for their ability 
to bind the SH3 domain of Pex13p 
 39
                                                                                                                                                       Results 
Recombinant and purified Pex13p (aa 271-344) and His6-tev-Pex14p (aa 1-80W) or His6-tev-
Pex14p (aa 1-108) were mixed in an 1:1 ratio and incubated with Ni-NTA beads. The N-
terminal his-tagged Pex14p constructs served as bait and were checked for their ability to pull 
down Pex13p. While both constructs were able to bind Pex5p (aa 214-335) in vitro (Fig. 3.5), 
no interaction with the SH3 domain of Pex13p was observed (Fig. 3.7). 
 
 
Fig. 3.7: Pull down assays of purified 
recombinant Pex13p (aa 271-344) and His6-
tev-Pex14p (aa 1-80W) (A) or His6-tev-
Pex14p (aa 1-108) (B). Proteins were mixed 
and incubated with Ni-NTA beads. Samples 
of proteins in total (t), flow through (ft) and 
Ni-NTA beads (b) were separated by SDS-
PAGE and analyzed by Coomassie staining. 
 
 
 
Additionally, 1H15N HSQC spectra of Pex14p (aa 16-78) alone and after addition of a 2 fold 
excess of Pex13p (SH3) were recorded and superimposed. No chemical shift perturbation of 
N-terminal Pex14p could be observed (Fig. 3.8), leading to the conclusion that the Pex13p 
construct used is either not functional or the SH3 domain alone is not sufficient to bind 
Pex14p. 
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Fig. 3.8: Overlay of the 
1H15N HSQC of 0.8mM 
Pex14p (aa 16-78) alone 
(blue) and after addition of 
a 2 fold excess of Pex13p 
(aa 271-344) (green). 
Spectra were recorded at 
500 MHz and 303K. 
Experimental time was 20 
minutes. 
 
 
 
 
 
 
 
 
 
3.6   Comparison of the 1H15N-HSQC spectra of Pex14p (aa 16-78) and 
 Pex14p (aa 16-80W) 
 
In order to investigate the influence of the additional tryptophane W81 on the binding 
properties of Pex14p or on the tertiary structure of the protein, 1H15N-HSQC spectra of 
Pex14p (aa 16-78) and (aa16-80W) were recorded and superimposed (Fig. 3.9). Both spectra 
are identical except for the additional residues. No peaks are shifted proving that the proteins 
are folded equally. 
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Fig. 39:  
Overlay of the 1H15N-
HSQC of Pex14p (aa 16-
78) (red) and Pex14p (aa 
16-80W) (blue). Except 
of the additional residues 
the spectra are identical. 
Spectra were recorded at 
500 MHz for 20 minutes.
 
 
3.7   Structural studies of N-terminal Pex14p by NMR 
 
3.7.1   Backbone assignment of free and peptide bound N-Pex14p 
 
Backbone resonance assignments of free and complexed Pex14p (aa 16-80W) were obtained 
using standard triple resonance experiments (Material and Methods, paragraph 2.2.11.1). 
While the backbone of the protein in complex with the Pex5p peptide (aa 116-124) and 
Pex19p (aa 66- 77) could be assigned completely, 6 residues were missing for free N-Pex14p 
(39, 41, 45, 55, 57, 70). Comparison of the secondary chemical shifts of free and bound 
Pex14p (aa 16-80W) show a three helical bundle in both cases. While in complex the linker 
between α1 and α2 appears to be helical, it seems more flexible in the free protein (Fig. 3.10). 
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Fig. 3.10: Secondary chemical shifts (Δδ(Cα-Cβ)) are indicated as black bars. Solvent protected 
amide protons are displayed by red circles. Secondary structure elements are shown above the 
sequence. 
 
 
Compared to free Pex14p, where only the scaffold helix α3 is solvent protected, complexed 
Pex14p shows slowly exchanging amide protons at helix α1 and α2. Depending on the ligand, 
the helical linker between helix α1 and α2 (Pex14p-Pex5p), or the loop region between helix 
α2 and α3 (Pex14p-Pex19p) is also protected. 
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3.7.2   Secondary structure of free and Pex14p-bound peptides 
 
 
Fig. 3.11: Hα secondary chemical shift for the 
residues 66-77 of the Pex19p peptide (A) and 
residues 116-124 of the Pex5p (B). Free and bound 
Pex19p are shown in light and dark blue, free and 
bound Pex5p in light and dark red. Ring current 
effects on the residues E68, F70 and for Pex19p and 
the residues N117 and W118 of the Pex5p peptide 
were accounted for calculation. Error bars are 
shown in black. 
Secondary structure defining NOEs of Pex19p (C) 
and Pex5p peptides (D) bound to Pex14p.  
 
 
Homonuclear TOCSY and NOESY experiments were used to characterize free Pex5p and 
Pex19p peptides while heteronuclear 12C/14N -filtered TOCSY and NOESY experiments were 
recorded for the bound form (see paragraph 2.2.11). The helical conformation of the bound 
peptides could be confirmed by Hα secondary chemical shifts and helical (i,i+3) NOE 
connectivities. The comparison of the free peptide versus Pex14p-bound indicates a reduced 
α-helical content in the free Pex19p peptide suggesting induced folding upon binding. In 
contrast the secondary chemical shifts of the free Pex5p peptide indicate already a mainly 
helical conformation. The average ring current shifts were determined from the ten lowest 
energy complex structures by the program MOLMOL and the shifts of residues Gln117, 
Trp118 of Pex5p and Glu68, Phe70 of Pex19p were corrected accordingly for secondary 
chemical shift calculation (see paragraph 2.2.11.4).  
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3.7.3   Relaxation Experiments 
 
 
15N relaxation data including T1, T2 and 15N heteronuclear NOE were recorded at 500 MHz 
for free and Pex5p bound N-terminal Pex14p. The first and last 7 amino acids of Pex14p (aa 
16-80W) show low 15N heteronuclear NOE values (below 0.5) and therefore high flexibility. 
Residues 24 to 73 are more rigid and constitute the structured part of the domain.  
In comparison to the average behavior of the molecule, some differences in the relaxation 
parameters are apparent in the bound form of Pex14p versus the free protein. The linking 
regions between the helical elements of bound Pex14p have lower values than the average T1.  
In contrast very little variation in T1 was observed across the entire free protein. Comparison 
of bound and unbound Pex14p shows a 2 fold decrease of T2 upon binding of the Pex5p 
peptide. The correlation time decreases from 8.2ns at 303K for free N-terminal Pex14p to 
4.2ns for the bound form. The linear relation between correlation time and molecular weight 
suggests that an N-terminal Pex14p dimer gets disrupted upon the addition of Pex5p peptide 
ligand. Fig. 3.12 provides an overview of relaxation data of free and bound N-terminal 
Pex14p. Although a biological relevance of this dimerization can not be excluded, it is very 
likely that it results from the high concentration of the NMR sample. 
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Fig. 3.12: Overview of free and bound N-terminal Pex14p relaxation data. 
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3.7.4   Structure of N-Pex14p in complex with a Pex5p and a 
 Pex19p ligand 
 
An almost complete assignment of Pex14p (aa 16-80W) in complex with a Pex5p peptide (aa 
116-124) was obtained following the iterative step procedure as described in Materials and 
Methods 2.2.11. The 3-dimensional structure was calculated by a simulated annealing 
protocol using the program ARIA1.2 (Linge et al., 2001) based on the experimentally 
determined distance, dihedral and dipolar coupling.  
The NMR spectra of the Pex14-Pex19p complexes were strongly dependent on the protein-
ligand ratio. Therefore, and due to stability reasons all spectra were recorded on a single 
sample with a 2.5 fold excess of Pex19p ligand. This includes the filtered spectra, which were 
used to assign and derive restraints for the bound peptide. The degree of saturation is 36% for 
the peptide (FLB) and 89% for the protein (FPB), calculated  
 
FLB = [PL]/[L]0 and FPB = [PL]/[P]0 
 
with the starting concentration of the protein [P]0 and the ligand [L]0. The complex 
concentration [PL] was determined by: 
 
[PL] = ½ (Kd + [P]0 + [L]0)-(¼ (Kd + [P]0 + [L]0)2 - [L]0 [P]0)½ 
  
with the dissociation constant Kd (= 9.23 µM, see Table 3.3). The Pex14p-Pex19p complex is 
in the fast binding regime on the chemical shift time scale and shows a spectrum representing 
the weighted average of the free and bound ligand signals. Nevertheless, deriving distance 
restraints from the filtered NOESY spectra should not introduce notable errors since the free 
Pex19p exists mainly in a random coil conformation and the NOESY spectrum of the free 
peptide is virtually void of cross-peaks (see Appendix II 7.2 ). Therefore, it is safe to assume 
that the sequential and long-range NOEs in the X-filtered NOESY experiments correspond to 
the bound form of Pex19p.  
Table 3.2 and 3.3 provide an overview of the structural statistics of Pex14p (aa 16-80W) in 
complex with a Pex5p or Pex19p ligand. A total number of 1030 intraresidual restraints and 
85 interresidual restraints for the Pex14p-Pex5p complex, as well as 904 and 127 for the 
Pex14p-Pex19p complex, were employed in the structure calculation. Structure quality and 
precision are satisfactory for the final ensemble including no distance or torsion angle 
violation higher than 0.5 A and 5°, respectively and is confirmed by superimposition of the 
low energy structures (Fig. 3.13 (A) and (B)) 
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Table 3.2: Structural statistics of the Pex14p (aa 16-80W) and Pex5p (aa 116-124) complex. 
 
<SA> 1  <SA>water-ref 
Number of NOE derived distance restraints  
All (unambiguous/ambiguous) 
1115 / 3 
 Sequential ( |i-j| = 1) 
 Medium range ( 1< |i-j| ≤ 4) 
 Long range ( |i-j| > 4) 
 Intraresidual  
 Hydrogen bonds 
Pex14p intramolecular(unambiguous/ambiguous) 
Pex5p intramolecular(unambiguous/ambiguous) 
Intermolecular(unambiguous/ambiguous) 
 
199 / 0 
107 / 0 
149 / 0 
575 / 0 
2* 19 
925 / 1 
105 / 0 
85 / 2 
R.m.s. deviation (Å) from experimental distance restraints 2  
R.m.s.d. (unambiguous)   0.01 ± 0.001   0.02 ± 0.001 
Hydrogen bonds (2* 19)   0.024 ± 0.003   0.029 ± 0.005 
     R.m.s. deviation (°) from experimental torsion restraints 3  
R.m.s.d. (52 φ/ψ)   0.32 ± 0.04   0.29 ± 0.05 
Q-factor for experimental residual dipolar coupling restraints 4 
1DHN (42)    0.13 ± 0.01   0.19 ± 0.01 
 
Coordinate Precision (Å) 5 
N, Cα, C’ 0.36 ± 0.06   0.46 ± 0.06 
All heavy atoms  
 
0.86 ± 0.09   0.95 ± 0.1 
Structural quality 6 
Bad contacts  1 ± 0.9   0 ± 0 
Ramachandran plot 
% in most favored region 
% in additionally allowed region 
 
91.3 ± 2.1 
 8.4 ± 1.9 
 
94.4 ± 3.6 
4.9 ± 2.2 
 
1<SA> is an ensemble of 10 lowest-energy solution structures (out of 100 calculated) of the Pex14p/Pex5p 
complex before water-refinement. The CNS Erepel function was used to simulate van der Waals interactions with 
an energy constant of 25.0 kcal mol-1 Å-4 using “PROLSQ” van der Waals radii (Linge et al., 2003); r.m.s. 
deviations for bond lengths, bond angles and improper dihedral angles are 0.00206 ± 0.00008 Å, 0.41 ± 0.01° 
and 0.468 ± 0.015°. 1 kcal = 4.18 kJ.  
2Distance restraints were employed with a soft square-well potential using an energy constant of 50 kcal mol-1 
Å2. For hydrogen bonds, distance restraints with bounds of 1.8-2.3 Å (H-O), and 2.8-3.3 Å (N-O) were derived 
for slow exchanging amide protons. No distance restraint was violated by more than 0.3 Å in the <SA> 
structures. 
 
(see next page) 
 
 
 
 
 48
                                                                                                                                                       Results 
Table 3.3: Structural statistics of the Pex14p (aa 16-80W) and Pex19p (aa 66-77) complex. 
 
 <SA> 1 <SA>water-ref 
Number of NOE derived distance restraints  
All (unambiguous/ambiguous) 
 Sequential ( |i-j| = 1) 
 Medium range ( 1< |i-j| ≤ 4) 
 Long range ( |i-j| > 4) 
 Intraresidual  
 Hydrogen bonds 
Pex14p intramolecular(unambiguous/ambiguous) 
Pex5p intramolecular(unambiguous/ambiguous) 
Intermolecular(unambiguous/ambiguous) 
1015 / 15 
111 / 8 
151 / 2 
175 / 2 
467 / 2 
2* 20 
777 / 13 
127 / 1 
111 / 1 
R.m.s. deviation (Å) from experimental distance restraints 2  
R.m.s.d. (unambiguous)   0.014 ± 0.001   0.023 ± 0.001 
Hydrogen bonds (2* 19)   0.026 ± 0.002   0.034 ± 0.005 
R.m.s. deviation (°) from experimental torsion restraints 3  
R.m.s.d. (52 φ/ψ)   0.27 ± 0.06   0.40 ± 0.08 
 
Coordinate Precision (Å)  
N, Cα, C’ 0.51 ± 0.11   0.55 ± 0.07 
All heavy atoms    1.106 ± 0.10   1.07 ± 0.08 
Structural quality 6 
Bad contacts  1.2 ± 0.6   0 ± 0 
Ramachandran plot 
% in most favored region 
% in additionally allowed region 
  
86.9 ± 1.9 91.7 ± 2.0 
  7.8 ± 2.1  13.1 ± 1.9 
 
 
 
 
 
 
3Dihedral angle restraints derived from TALOS (Cornilescu et al., 1999) were applied to φ, ψ backbone 
angles using energy constants of 200 kcal mol-1 rad-2. No dihedral angle restraint was violated by more than 
5.0°. 
4Quality factor for the RDC refinement (Cornilescu et al., 1999). Residual dipolar couplings were applied 
with a final energy constant of 0.05 kcal mol-1 Hz-2 for an alignment tensor with an axial component of 19 
Hz and a rhombicity of 0.37. 
5Coordinate precision is given as the Cartesian coordinate r.m.s. deviation of the 10 lowest-energy structures 
in the NMR ensemble (residues 24-73 of Pex14p, 117-124 of the Pex5p peptide and 67-77 of the Pex19p 
peptide) with respect to their mean structure. 
6Structural quality of the NMR ensemble before and after water refinement was analyzed using 
PROCHECK-NMR (Laskowski et al., 1996). 
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Fig. 3.13: Structure of the N-terminal Pex14p domain in complex with a Pex5p or Pex19p peptide 
(A) Stereo view of the backbone atoms of the N-terminus of Pex14p (residues 19-76) in complex 
with the residues 116-124 of Pex5p. An NMR ensemble of the 10 lowest-energy structures (out of 
100 calculated) is shown. The helices α1, α2, α3 and the helical linker between α1 and α2 of the 
protein are colored in green. The peptide is shown in gold. The side chains of Trp103 and Phe106 are 
highlighted. 
(B) Ribbon diagram of the lowest energy structure in (A). The residues Trp103 and Phe106 of the 
peptide are shown as sticks representation. 
(C) best-fit superposition of the backbone atoms of Pex14p (aa 19-76) in complex with Pex19p (aa 
66-77). The ensemble shows 10 low-energy structures (out of 100 calculated). The peptide is shown 
in brown, the aromates Phe71and Phe75 of the Pex19p peptide are highlighted.  
(D) Ribbon presentation of the lowest energy structure in (C). The residues Phe71 and Phe75 of 
Pex19p are displayed as sticks.
 
 
The complex consists of three α-helices and a helical linker between helix α1 and α2. This 
linking region shows typical features of a 310 helix, such as a (i,i+3) hydrogen bond of the 
backbone carbon and amide atom of the residues 40 and 41 and Φ/Ψ angles of -93° ± 9/-28° ± 
11, -60° ± 5/-35° ± 6, -58° ± 3/-29° ± 9 and -108° ± 11/-6° ± 23 for the residues R40, V41, 
R42 and N43 of Pex14p (calculated by MOLMOL as the average value of the 10 lowest 
energy structures of the Pex14p-Pex5p complex). 
Helix α1 and α2 of N-Pex14p are aligned in an anti-parallel orientation (Fig. 3.13). Helix α3 
forms a stabilizing scaffold in a transverse arrangement from the tip of helix α2 to the bottom 
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of helix α1 and does not contribute to the binding. The bound Pex5p or Pex19p peptide forms 
an amphipathic α-helix whereas Pex19p is oriented in the opposite direction compared to 
Pex5p. No evidence was found that Pex19p can bind in both orientation and all observed 
intermolecular NOEs can be accounted for the inverse interaction. Fig 3.14 shows a cut out of 
a 1H1H-NOESY spectra. Intermolecular NOEs between the peptide residues Phe70, Phe71 of 
Pex19p and V41 of Pex14p as well as Phe75 and T31 demonstrate clearly the inverse 
orientation. The large distance of about 10Å between these residues makes the assignment 
unambiguous. 
 
 
Fig 3.14: (A) Part of a 1H,1H-NOESY (600 MHz, 200ms mixing time, 303K) depicting NOEs 
between Pex14p (black) and Pex19p (brown). The peptide residue Phe70 and Phe71 show NOEs to 
residue V41 of Pex14p. Residue Phe75 of Pex19p interacts with residue T31 of the protein (B) 
Ribbon diagram of N-terminal Pex14p in complex with Pex19p. The residues Phe70, Phe71 and 
Phe75 of Pex19p and V41 and T31 of the protein are shown as sticks. The black bar indicates a 
 
 
The protein-peptide binding interface is 390A2 for Pex14p-Pex5p and 460A2 for Pex14p-
Pex19p large (calculated according to (Richards, 1977), via the program NOC) and is mainly 
stabilized by hydrophobic interactions. The N-Pex14p interaction surface is built up by 
residues from helices α1 and α2, as well as the linking elements between α1-α2 and α2-α3, 
respectively. It forms two hydrophobic pockets, separated by two aromatic residues (F35 and 
F52), which are flanked by basic amino acids; leading to a positive charged protein surface. 
One of these basic residues, K56 of Pex14p, is highly conserved (Fig. 3.16). 
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Intermolecular NOEs from Pex14p residues L28, T31, F35, N38, R40, V41, S44, T48, R49, 
F52, L53, K56, L58 to residues Trp118, A119, F122 and Leu123 of Pex5p were used as 
distance restraints to calculate a structural ensemble of the N-Pex14p-Pex5p complex. The 
amino acids Phe70, Phe71, Leu74, Phe75, Asp76 and Ser77 of Pex19p interact with similar 
residues, but while additional NOEs to the residues K34 and P44 could be identified, the ones 
to R49 and L53 were missing for the Pex14p-Pex19p complex (Fig 3.15). Compared to the 
helix of the Pex5p peptide, which is centered between helix α1 and α2 of the protein, the 
hydrophobic side chains of the Pex19p peptide are oriented to a larger extent towards helix α1 
of Pex14p (Fig.3.15 (A) and (B)). 
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Fig. 3.15: (A) and (B) Worm and stick model of the molecular recognition interface of Pex14p and 
Pex5p (A) and Pex14p and Pex19p (B). The protein is shown in grey, the peptide in gold or brown. 
Helical elements of Pex14p are green. Positive and negative charged residues are colored in blue and 
red, respectively.  Protein residues contributing to intermolecular NOEs are labeled. 
(C) and (D) schematic overview of the intermolecular NOEs between Pex14p and its ligand. Residues 
of Pex14p in loops are shown in grey, helical residues in green. The peptide residues are colored gold 
(Pex5p) and brown (Pex19p). 
 
The aromatic residues of the ligand, Trp118 and Phe122 of Pex5p or Phe71 and Phe75 of 
Pex19p insert directly into the Pex14p binding pockets (Fig. 3.16A and C). While the Pex14p-
Pex19p binding is only mediated by hydrophobic interactions, residue Glu116 of Pex5p forms 
a salt-bridge to the conserved protein residue K56. Structural calculations of the Pex19p 
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ligand suggest an intrahelical salt bridge. All 10 lowest energy structures calculated by ARIA 
show an orientation of Glu73 towards Lys69 of Pex19p. In 4 of the 10 lowest energy 
structures the distance between the residues is close enough to form a salt bridge. In 
comparison to Pex5p the Pex19p peptide is shifted half a helix turn “upwards” (Fig. 3.16).  
 
 
Fig. 3.15: Surface representation of the N-terminus of Pex14p and a stick representation for Pex5p 
(aa 116-124) (gold) or Pex19p (aa 66-77) (brown). The conserved K56 of Pex14p is indicate in white 
(A and C) Hydrophobic residues are colored green, hydrophilic light blue. Hydrophobic peptide 
residues are shown as sticks. (B and D) Electrostatic charge distribution, positive charges are 
indicated by blue colors, negative charges are shown in red. 
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3.7.5   Comparison of the Pex5p and Pex19p ligand interaction 
 
The orientation of the 3 helix bundle of N-Pex14p in complex with Pex5p is identical to the 
Pex14p-Pex19p complex. The backbone atoms within the helical regions of the protein 
superimpose with an r.m.s deviation of 0.9 Å, reflecting the differences between the two 
structures, especially in the interaction interface. Compared to the Pex14p-Pex5p interaction 
the helix α2 of Pex14p in complex with Pex19p is slightly shifted, allowing a tighter packing 
towards the aromatic peptide residue Phe75. The superimposition of the two peptide 
sidechains shows a strong similarity between the key residues of both peptides (Fig. 3.17).  
 
 
Fig. 3.17: Superimposition of N-Pex14p complexes. The Pex14p-Pex5p complex is displayed in 
gold, the Pex14p-Pex19p complex in brown. (A) Ribbon diagram of Pex14p-Pex5p and Pex14p-
Pex19p. Helix α2 angles are indicated by black bars. (B) Surface representation of N-Pex14p. 
Peptide residues inserting into the binding pockets are shown as sticks
 
 
The Trp118 of Pex5p and the Phe75 of Pex19p occupy the “upper” binding pocket in the 
same vertical orientation. Both residues can be accounted as the key anchor residues of the 
interaction with a ΔASA of 173Å2 and 158Å2, respectively. Phe71 (Pex19p) and Phe122 
(Pex5p) share a similar position in the “lower” binding pocket, whereas the Pex5p residue is 
oriented more towards the aromatic residues F35 and F52 of the protein and inserts deeper 
into the binding pocket (ΔASA 118Å2 compared to 94Å2) In contrast to Phe70 of Pex19p, 
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which is embedded laterally in the “lower” binding pocket, the Leu123 of Pex5p is only 
attached peripherally (ΔASA 87Å2 for Phe70 compared to 25Å2 for Leu123). Sums of all key 
residues show a comparable change in accessible surface area (Table 3.2).  
 
Table 3.2: ΔASA of key residues  
 ΔASA  ΔASA 
5-Trp118 173 Å2 19-Phe75 158 Å2 
5-Phe122 118 Å2 19-Phe71 94 Å2 
5-Leu123 25 Å2 19-Phe70 87 Å2 
Σ 316 Å2  339 Å2 
3.8   Competitive binding of Pex19p and Pex5p 
 
3.8.1   NMR titration experiments 
 
To investigate the binding properties of Pex19p and Pex5p ligand competitive NMR titration 
experiments were performed. First Pex14p (aa 16-80) was titrated up to the point of saturation 
with Pex5p and Pex19p peptide alone. The change of chemical shifts was monitored via a 2-
dimensional 1H15N-HSQC. Mapping of perturbed backbone amide signals upon Pex5p or 
Pex19 addition onto the surface of N-Pex14p reveal a well overlapping binding groove 
between helices α1 and α2 and the connecting linker l1 (Fig. 3.18C). While the peaks of the 
N-Pex14p-Pex19p were in fast exchange on the chemical shift time scale, the resonances of 
the N-Pex14p-Pex5p complex are in slow exchange, suggesting a tighter binding of the Pex5p 
ligand. In a third experiment N-Pex14p was first titrated with Pex19p peptide and then cross-
titrated with the Pex5p ligand. The chemical shift perturbation was monitored again and 
compared with the single titration experiments (Fig. 3.18C). The endpoints of the cross-
titration (Fig. 3.18B) are identical with the single titration (Fig. 3.18A), suggesting that 
Pex19p ligand is quantitatively replaced by the stronger binding Pex5p peptide. 
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Fig. 3.18: Competitive NMR titration of N-terminal Pex14p with a Pex19p and Pex5p peptide 
(A)1H,15N correlation spectra of 15N-labeled recombinant N-terminal Pex14p (aa 16-80W) in free 
form (black) and in complex with Pex19p peptide (aa 61-77) (blue) and Pex5p (red) (aa 116-124). (B) 
Free 15N-labeled recombinant Pex14p (aa 16-80W) (black) was titrated with Pex19p peptide (aa 61-
77) (blue) to the point of saturation. The complex was cross-titrated with Pex5p peptide (aa 116-124)
(red). (C) NMR chemical shift changes (Δδ=(δ15Ν2+δ1Η2)1/2) of Pex14p (aa 16-80W) in the presence 
of saturated concentrations of the Pex5p (red) and the Pex19p (blue) ligand. Secondary structure 
elements are indicated at the top of the sequence. 
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3.8.2   Isothermal titration calorimetry  
 
To verify and to quantify the NMR titration data ITC experiments were performed.  As 
expected both ligands form a 1:1 complex with N-terminal Pex14p.  
 
 
Fig. 3.19: ITC of N-Pex14p with a Pex5p or a Pex19p ligand 
Representative raw ITC data (top) and integrated data fits (bottom) are shown for Pex14p (aa 16-
80W) with Pex5p (aa 116-124) (left) and Pex14p (aa 16-80W) with Pex19p (aa 61-77) (right). All 
experiments were conducted at 25°C in 50mM potassium phosphate buffer pH 6.5 supplemented with 
100mM NaCl. Ligand dilution controls were substracted. 
 
 
The binding of the Pex5p peptide is about 20 times stronger than the Pex19p-Pex14p 
interaction (with a Kd of 0.45µM compared to 9.13µM). Both reactions are enthalpy driven. 
The free energy of the Pex14p-Pex5p interaction is about 20% higher than the  
energy of the Pex14p-Pex19p interaction (36.2kJ/mol to 28.8kJ/mol). Entropy values of both 
interactions are in the same range of -0.16 kJ/molK (Pex14p-Pex5p) and -0.1 kJ/molK 
(Pex14p-Pex19p). Table 3.3 shows a summary of the binding data. 
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Table 3.3: Summary of the binding thermodynamic parameters of the N-Pex14p-ligand interactions 
Reaction N Ka  x105 
(M-1) 
Kd 
(µM) 
ΔH 
(kJ mol-1) 
ΔS 
(J mol-1 K-1) 
ΔG 
(kJ mol-1) 
Pex14p (aa 16-80W) 
– Pex5p (aa 116-124) 
 
 
1.02 0.03 ±
 
22.2 ± 0.78 
 
0.45 ± 0.02 
 
-83.4 ± 1.02 
 
-159.5 3.6 ±
 
-36.2 ± 0.88 
Pex14p (aa 16-80W) 
– Pex19p (aa 61-77) 
 
1 ± 0.07 
 
1.14 ± 0.29 
 
9.13 ± 2.26 
 
-59.5 ± 0.65 
 
-103 3.6 ±
 
-28.8 ± 0.63 
 
 
Fig. 3.20 shows a qualitative ITC experiment. Addition of Pex5p to an N-Pex14p-Pex19p 
complex leads to a heat release, whereas addition of Pex19p to an N-Pex14p-Pex5p complex 
does not cause further release of free energy.  
 
 
Fig. 3.20: Qualitative ITC experiment 
Raw ITC data of the titration of a Pex14p (aa 16-80W)-Pex19p (aa 61-77) complex with Pex5p (aa 
116-124) (left) and a Pex14p (aa 16-80W)-Pex5p (aa 116-124) with Pex19p (aa 61-77) (right). Both 
experiments were conducted in 50mM potassium phosphate buffer pH 6.5 supplemented with 
100mM NaCl at 25°C. Ligand dilution controls were substracted 
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4 Discussion 
 
 
The principles of peroxisomal protein import are well conserved among the species. Four 
stages can be distinguished: cargo recognition, docking to the peroxisomal membrane, cargo 
release and receptor recycling (overview by Erdmann and Schliebs, 2005). Pex14p is a central 
component of the docking complex and interacts with the PTS receptors Pex5p and Pex7p 
(Brocard et al., 1997; Rehling et al., 1996), as well as with several other membrane bound 
peroxins. Human Pex14p comprises different functional domains, i.e. a highly conserved N-
terminal region, a hydrophobic segment, and a coiled coil domain. The N-terminus of Pex14p 
interacts with the PTS1 receptor Pex5p, Pex13p, a member of the peroxisomal docking 
complex (Albertini et al., 1997) and the multifunctional protein Pex19p (Fransen et al., 2004).  
This work presents functional und structural studies of the N-terminus of human Pex14p in 
complex Pex5p and Pex19p and provides insight into the molecular details of the early steps 
of peroxisomal protein import.  
 
 
4.1   Definition of domain borders of N-terminal Pex14p 
 
So far the only two biophysical techniques that allow structural studies at atomic resolution 
are X-ray crystallography and NMR spectroscopy. A starting point for both methods is the 
availability of a well structured and soluble protein target. Although several studies defined 
domain borders N-terminal of human Pex14p (Fransen et al., 2004; Itoh and Fujiki, 2006; 
Saidowsky et al., 2001), these were characterized rather on functional than structural aspects 
and are mainly based on the ability of N-Pex14p truncation constructs to bind to a ligand. An 
exopeptidase assay performed for the present study defined a globular N-terminal domain of 
Pex14p reaching from residue 16 to 78. NMR relaxation experiments revealed a slightly 
shorter structured region comprising amino acids 24 to 73. The residues preceding and 
following this domain, displayed a high flexibility, an observation that possibly provides an 
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explanation for the failure to obtain crystals of N-terminal Pex14p-constructs with more than 
these 50 residues. On the other hand protein constructs comprising only the structured part of 
the N-terminal domain turned out to be insoluble. Protein insolubility is often a result of 
misfolding (Dobson and Karplus, 1999), thus the insolubility of these constructs could 
possibly indicate protein misfolding and implicate the requirement of these flexible residues 
for structural stabilization of the domain.  
 
4.2   Large scale in vitro complex formation of N-terminal Pex14p and 
 different ligands 
 
During the last years several studies of mammalian Pex14p and its ligands were published 
(Fransen et al., 2002; Fransen et al., 2001; Itoh and Fujiki, 2006; Otera et al., 2002; Reguenga 
et al., 2001; Saidowsky et al., 2001; Will et al., 1999). Most of the interaction studies were 
carried out by using recombinant or endogenous proteins in pull down assays. On the basis of 
these publications and as a prerequisite for crystallization trials, we established extensive, 
large scale in vitro complex formation between N-terminal Pex14p constructs and different N- 
and C-terminal Pex5p constructs or N-terminal Pex19p. Although all complexes were soluble 
and showed high purity, crystallization failed. Interestingly, we were able to show interaction 
between N-terminal Pex14p and Pex5p (aa 268-639), a construct, whose WxxxF/Y motif has 
been reported to show no or very low in vitro interaction with N-terminal Pex14p (Otera et 
al., 2002; Saidowsky et al., 2001). This discrepancy may be due to various causes, such as 
different experimental conditions, higher sample concentrations or a stabilizing influence of 
the structured TPR domain.  
 
 
4.3   N-terminal Pex14p does not interact with the SH3 domain of 
 Pex13p in vitro 
 
The interaction of a classical PxxP II motif of N-ScPex14p with the SH3 domain of ScPex13p 
has been clearly demonstrated on a molecular level (Douangamath et al., 2002). However, 
there seem to be differences between yeast and higher eukaryotes. Mammalian Pex14p lacks a 
classical PxxP II motif, but has several non canonical PxxP motifs in its N-terminus. Recent 
studies locate the Pex13p binding site at the conserved N-terminal domain of Pex14p 
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(Fransen et al., 2004; Otera et al., 2002), even narrowing down the respective region to a few 
residues containing a PxxP motif (Itoh and Fujiki, 2006). The same studies suggested an 
influence of the Pex13p-Pex14p interaction on the binding behavior of Pex14p to Pex5p and 
to Pex19p. To specify these influences we investigated the interaction of N-Pex14p and the 
SH3 domain of Pex13p. Surprisingly, in vitro binding assays revealed no interaction between 
the two domains. These results could be confirmed by NMR experiments since fingerprint 
spectra of N-terminal Pex14p show no chemical shift perturbation upon addition of Pex13p-
SH3 and thus no interaction. A major difference between the studies mentioned above and 
ours lies in the different length of Pex13p constructs used. While the interaction data 
described in these publications was based on Pex13p constructs comprising the whole C-
terminus of Pex13p, the construct used in this study contained only the SH3 domain. 
Although it can not be excluded that the recombinant SH3 construct used was misfolded and 
not functional, it might also be possible that the SH3 domain of human Pex13p alone is not 
sufficient to bind N-terminal Pex14p. Nevertheless, current data is limited and further 
experiments will be required to investigate this phenomenon. 
 
 
4.4   Three dimensional fold of N-terminal Pex14p 
 
The N-terminal Pex14p domain consists of a 3-helical bundle. Helices α1 and α2 are aligned 
in an antiparallel orientation and together with the linker regions between helix α1/α2 and 
α2/α3, form a groove which buries hydrophobic ligands. Helix α3 provides a stabilizing 
scaffold and does not contribute to the binding. The interaction interface overlaps well with 
the conserved signature sequence AX2FLX7SPX6FLKXKGL/V present in all Pex14p proteins 
described previously (Madrid and Jardim, 2005). The linking element between helix α1 and 
α2 is flexible in free Pex14p and adapts helical conformation upon ligand binding. Depending 
on the ligand, helix α2 is slightly shifted. This displacement causes an enlargement of the 
“upper” and narrowing of the “lower” binding pocket on Pex5p binding. The structural 
arrangements upon ligand binding can be accounted as an induced fit mechanism (Jorgensen, 
1991; Koshland, 1958) providing optimal interactions resulting in a tightly packed interface. 
In addition to hydrophobic interactions the Pex5p binding is stabilized by an additional salt-
bridge. While the Pex5p ligand is centered between the two interface helices, Pex19p is 
oriented towards helix α1. This leads to a larger protein-peptide interface and potentially 
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stronger hydrophobic interactions between Pex14p and Pex19p. This is consistent with 
previous findings that an N-terminal Pex14p construct with a truncated helix α1 is still able to 
bind Pex5p but not Pex19p (Itoh and Fujiki, 2006).  
 
 
4.5   Pex19p and Pex5p compete for the same Pex14p binding site 
 
Previous studies have shown that Pex19p and Pex5p bind to the same N-terminal domain of 
Pex14p (Fransen et al., 2004; Itoh and Fujiki, 2006). Although these studies indicated that this 
binding might be competitive and Pex5p was likely the stronger interaction partner, no details 
were known. In order to investigate and quantify the binding properties of the Pex14p ligands 
Pex5p and Pex19p we carried out NMR and ITC experiments. Cross titration showed that the 
Pex5p peptide can quantitatively replace Pex14p-bound Pex19p, while Pex19p is not able to 
substitute bound Pex5p. The collected ITC data characterize the Pex5p-Pex14p binding about 
20 times stronger than Pex19p-Pex14p interaction. Interestingly, dissociation constants 
received for the Pex14p-Pex5p complex are about one magnitude higher than reported 
previously (Saidowsky et al., 2001). An explanation for this discrepancy could lie in the 
different experimental approach (Surface plasmon resonance spectroscopy and fluorescence 
titration analysis compared to isothermal titration calorimetry) or in the different length of 
measured peptides (see paragraph 4.7).  
The NMR fingerprint spectra of the titration of N-terminal Pex14p with a Pex5p and a Pex19p 
peptide, respectively, reveal an identical binding groove. These results support our three-
dimensional models of both the Pex14p-Pex19p and Pex14p–Pex5p complex and contrasts 
recent suggestions that competition could occurs via induction of structural changes, rather 
than by direct competition for binding sites (Fransen et al., 2004). The lower affinity of 
Pex19p suggests a more intermediate character of the Pex14p-Pex19p interaction while the 
stronger binding of Pex5p to Pex14p would suit its role in the early steps of peroxisomal 
protein import (see paragraph 4.9).  
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4.6  Molecular details of ligand recognition 
 
Protein interactions involve the specific complementary recognition of two molecules to form 
a stable complex. Thereby recognition depends mainly on a few critical residues at the 
binding interface, which are often conserved. The association processes is driven by different 
favouring factors like hydrophobic and electrostatic interactions and shape complementarity 
(Bogan and Thorn, 1998; Jones and Thornton, 1996; Valdar and Thornton, 2001).  
Our studies revealed that Pex19p and Pex5p bind to Pex14p in a similar manner, although 
Pex19p lacks a classical WxxxF/Y motif (Fransen et al., 2005). Both peptides form an 
amphipathic helix which allows their aromatic residues to insert into the Pex14p binding 
pockets, forming the main anchors of interaction. The aromatic residues of the conserved 
WxxxF/Y motif are deeply buried into two binding pockets at the Pex14p interaction 
interface. The interaction is stabilized by a salt-bridge between the conserved K56 of Pex14p 
and Glu121 of Pex5p. Compared to Pex5p, Pex19p binds in a reverse orientation and is 
shifted towards the “upper” binding pocket, in which a C-terminal phenylalanine mimics the 
tryptophan of Pex5p. The Pex14p-Pex19p complex lacks an intermolecular salt bridge but the 
Pex19p ligand is stabilized by a potential intrahelical salt bridge between Lys69 and Glu73. 
Intrahelical (i,i+4) salt bridges contribute to helix stability by a value of up to -0.5 kcal/mol 
(Lyu et al., 1992). The change in accessible surface area of the residues in both complexes is 
similar (paragraph 3.7.5). The Pex14p-Pex19p interaction has an even larger overall 
interaction surface, which leads to potentially stronger hydrophobic interactions, a main 
driving force in the stabilization of protein associations (Chothia and Janin, 1975; Dill, 1990). 
Nevertheless, Pex5p binds stronger to Pex14p than Pex19p. One possible explanation may be 
found in the formation of the intermolecular salt bridge between Pex5p and Pex14p. Although 
the energy contribution of solvent exposed salt bridges to free binding energy is rather low (-
0.16-1 kcal/mol) (Brown et al., 1978; Louie et al., 1988), they lead to a decrease in the off rate 
of complex association. Thereby the salt-bridge serves as a “latch”, which stabilizes the 
interaction by locking down forming complexes to their final position. (Kimura et al., 2001). 
Another reason for the higher binding affinity of Pex5p might be the different prefold of free 
ligands. The term prefold is used herein to describe the conformity in structural arrangement 
of the free and bound ligand. Secondary chemical shift analysis reveals a helical conformation 
for free Pex5p peptide. Although free Pex19p displays a helical tendency, the structural 
rearrangements upon binding appear to be larger compared to Pex5p. Structural 
rearrangements come along with a loss of translational and rotational freedom of amino acids 
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and oppose the association of proteins. A prefolded interaction motif leads to a faster 
recognition, an increase of the on rate of complex formation and therefore to higher binding 
affinities (Camacho et al., 2000; Kimura et al., 2001; Rajamani et al., 2004).  
 
 
4.7   Pex14p binds helical ligands in different orientations 
 
Although it has been reported that Pex14p is able to bind an inverse WxxxF/Y motifs in 
S.cerevisae, the reverse orientation of the FxxxF Pex19p peptide was unexpected, but can be 
explained on a molecular level. Regular orientation of Pex19p offers two alternatives how the 
aromatic side chains of Phe70, Phe71 and Phe75 can insert into the Pex14p binding pockets: 
one would lead to a complete mismatch of the amphipathic helix (Fig. 4.2A-3 and 4.2B-3), 
the other to a sterically unfavorable alignment of key residues by switched positions of the 
medium-size hydrophobic residue Leu74 and the bulky anchor residue Phe71. (Fig. 4.2A/B-2 
and 4.2A/B-4). The salt bridge formation possible to form between K56 of Pex14p and Glu73 
of Pex19p is either not sufficient to stabilize this orientation or may even have the opposite 
effect by removing a favorable intrahelical salt bridge between Lys69 and Glu73. Regular 
orientation would further lead to unfavorable contacts of hydrophilic Pex19p residues to the 
surface of Pex14p (Fig 4.2B-3 and -4). In contrast, a C-terminal elongation of the observed 
inverse Pex19p and N-terminal elongation of the Pex5p helix show a perfect match between 
hydrophobic ligand residues and protein surface (Fig 4.2B-1 and -2). The additional contact 
surface probably enhances both binding affinity and complex stability. This is consistent with 
studies showing that longer amphipathic peptides elicit higher affinity to the N-terminus of 
Pex14p (Choe et al., 2003).  
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Fig. 4.2: (A) Helical wheel representation (Schiffer and Edmundson, 1967) of the Pex5p (aa 116-
124) peptide (1), the inverse orientation (2) and the regular orientation I (3) and II (4) of Pex19p (aa 
66-77) in complex with Pex14p. Basic residues are coloured in blue, acidic ones in red and 
hydrophobic ones in green. Small or neutral residues were left blank. Residues inserting into the 
binding pockets are marked by an asterisk. Salt bridge formation to K56 of Pex14p is indicated by 
dashed lines. (B) Alignment of Pex5p and Pex19p peptide in different orientations. Gray letters 
display the elongated ligand sequence, black letters the peptide sequence used in this study. Residues 
facing the Pex14p protein surface are indicated in light green. 
 
The ability to bind to helical peptides in either direction is a feature that Pex14p shares only 
with calmodulin, Sin3 corepressor PAH2 domain and SH3 domains (Hoeflich and Ikura, 
2002; Kuriyan and Cowburn, 1997; Swanson et al., 2004) (Fig. 4.2).  
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Fig. 4.2: Examples of modular domains with different ligand orientations: 
(A)Ribbon diagramm of the CaM-CaMKK (left) and CaMKII complex (right). (B) PH2 domain of 
the Sin3 corepressor in complex with Mad1 SID (left) and HBP1 SID (right). (C) ScPex13p SH3 in 
complex with the PPII motif of ScPex14p (left) c-CRK SH3 domain in complex with a PPI ligand 
(right). (D) N-terminal domain of hsPex14p in complex with the first WxxxF/Y motif of hsPex5p and 
the FxxxF motif of hsPex19p. 
 
 
The former two domains interact with short amphipathic helices, the later with polyproline 
helices. Ligand orientation of SH3 domains and calmodulin is determined by ionic 
interactions between positively charged residues in the peptide and their counterpart on the 
protein surface. The PAH2 domain of Sin3 recognizes a patch of conserved hydrophobic 
residues whose alignment also determines the orientation of the ligand. N-Pex14p appears to 
combine both features. As mentioned above, ligand orientation is mainly determined by the 
alignment of the WxxxF/Y motif in the protein sequence. In case of a pseudo-symmetrical 
motif like the FxxxF of Pex19p the ligand orientation is determinant by residues flanking the 
aromatic core motif. Thereby, sterical arrangement of large hydrophobic residues and ionic 
interactions between a conserved lysine and its counterpart in the ligand sequence serve as 
selection criteria. The inverse binding of the Pex19p ligand gives rise to the question if such a 
feature has evolved accidentally, or has a biological function to fulfill. 
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4.8   The N-terminus of Pex14p, a new modular domain? 
 
Protein-protein interactions are widely spread and probably involved in every biological 
process. Despite the large variety of interactions coupled with the differences in interfacial 
size and nature, two general classes of interactions can be discriminated. The domain-domain 
interaction is characterized by complexation of prefolded structural units, while domain-
peptide interactions comprise the binding of a structured component to a short, often 
unstructured, recognition motif (Wodak and Janin, 2002). The latter one is often divided into 
sub classes according to popular modules repeatedly found in homologous and modified 
forms. Such modules are compact, stable units with a typical three-dimensional structure, 
which can fold and function independently of the rest of the protein. The functions of modular 
domains are variable, but a large group is specialized in recognition of regular motifs and/or 
folds (Liddington, 2004). This study reveals that N-Pex14p displays characteristics of a new 
modular protein structure. The modular domain comprises about 50 residues and is conserved 
among the species. Its molecular scaffold consists of a three-helical bundle, recognizes a 
diaromatic motif and is the target of at least two different ligands, i.e. Pex5p and Pex19p, in 
mammals. The main function of the N-terminus of Pex14p certainly lies in the peroxisomal 
protein import. Nevertheless an involvement of the N-terminal part of Pex14p in peroxisomal 
degradation (Bellu et al., 2001) and a possible role as a corepressor of the transcriptional 
regulation factor NF-E2 has been reported (Gavva et al., 2002). 
 
 
4.9  Role of the Pex14p-Pex5p and Pex14p-Pex19p interaction 
 
It is generally accepted that Pex14p is a key component of the docking complex and plays a 
crucial role in the early steps of peroxisomal protein import. Nonetheless, the exact function 
of Pex14p is still unclear. While some studies propose it as the initial docking site of Pex5p, 
others suggest an involvement in formation and stabilization of a putative Pex5p import 
channel. A key argument for all proposed models is the localization of the N-terminal domain, 
which has been investigated by immunofluorescence and protease protection assays and has 
been reported to be cytosolic, luminal and/or embedded into the peroxisomal membrane 
(reviewed by Azevedo and Schliebs, 2006). Our structural data shows large clusters of 
hydrophilic residues on the domain surface, making a complete embedment into the 
peroxisomal membrane very unfavourable. However, the hydrophobic interaction interface of 
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N-terminal Pex14p is surrounded by an accumulation of positively charged residues, which 
could provide a perfect counterpart for the carboxyl headgroup of membrane lipids. This 
direct attachment to the peroxisomal membrane could occur on either site of the peroxisomal 
membrane and would probably sufficient to protect the N-terminus of Pex14p from proteases 
or antibodies. On the other hand, such a limited accessibility would also affect the recognition 
of a ligand, i.e. Pex5p. The problem would most likely be overcome, if Pex5p approximates 
the N-terminal domain from the membrane site. In such a model, Pex14p could stabilize, or 
anchor, membrane inserting Pex5p on the luminal site of the peroxisomal membrane (Fig. 
4.3).  
 
 
Fig 4.3: Model of the early steps of peroxisomal 
protein import. (A). The positively charged 
interaction surface of Pex14p (blue) faces the 
luminal site of the peroxisomal membrane. The N-
terminus of Pex5p containing the conserved 
WxxxF/Y motif (gold) approaches the membrane 
from the cytosolic site. (B). Pex5p inserts itself into 
the peroxisomal membrane. (C) Pex5p has 
penetrated the membrane completely. The 
WxxxF/Y binds to the N-terminus of Pex14p. In 
case of multiple WxxxF/Y motifs, the N-terminal 
domain would successively interact with each motif 
until the one with the highest binding affinity is 
reached. 
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Although the membrane insertion of Pex5p takes place independently of other proteins, as 
proposed before (Erdmann and Schliebs, 2005), the model implicates the requirement of other 
factors on the cytosolic site of the membrane which direct the Pex5p over the luminal position 
of the N-terminal domain of Pex14p. Studies in yeast have recently revealed a second Pex5p 
binding site in the C-terminal part of Pex14p (Niederhoff et al., 2005), providing a good 
candidate for such factor. Alternatively, Pex13p which interacts with both Pex14p and Pex5p 
(Erdmann and Blobel, 1996; Fransen et al., 2002) could fulfil this role. Azevedo and Schliebs 
(2006) suggested that the Pex14p-Pex5p interaction represents the minimum free energy state 
of Pex5p and that subsequent steps require energy. Our results show that the free energy of 
the Pex14p-Pex5p interaction (36 kJ) is in the same range as free energy provided by 
phosphorylation. Studies in H.polymorpha and P.pastoris revealed that at least parts of the 
Pex14p population are phosphorylated (Johnson et al., 2001; Komori et al., 1999). 
Interestingly, phosphorylation site prediction of the N-terminal domain shows a conserved 
motif in the helical linker between helix α1 and α2. It is tempting to speculate that 
phosphorylation in this region could lead to the disruption of the Pex14p-Pex5p interaction, 
allowing the release of Pex5p and/or the transfer to downstream interaction partners. 
Pex19p has been proposed as multifunctional protein. It has been assigned a role as receptor 
for PMPs, as chaperon or, in a more general way, as crucial factor in peroxisomal biogenesis 
(reviewed by Schliebs and Kunau, 2004). Rottensteiner et al. (Rottensteiner et al., 2004) 
defined a classical mPTS consisting of a transmembrane domain and an amphipathic helix of 
basic and hydrophobic residues. Although Pex14p lacks a typical Pex19p binding site, it is 
possible that its N-terminal interaction serves as an unusual recognition motif for Pex19p and 
holds therefore responsible for its targeting to the peroxisomal membrane. On the other hand 
previous studies have shown that Pex14p is mislocalized in Pex13p defective cells, indicating 
that the Pex14p-Pex19p interaction on its own is not sufficient to direct Pex14p to 
peroxisomal membrane (Fransen et al., 2004; Itoh and Fujiki, 2006). Studies in S.cerevisiae 
have shown that the N-terminus of Pex14p significantly contributes to the insertion of the 
protein into the peroxisomal membrane (Niederhoff et al., 2005). This could lead to the 
conclusion that the Pex19p interaction facilitates, perhaps with help of Pex13p, the correct 
orientation of Pex14p into, rather than its targeting to the peroxisomal membrane. Secondary 
chemical shifts and relaxation experiments suggest a higher flexibility of free Pex14p, 
indicating a better accessibility to proteases. Furthermore, we could observe a more rigid 
structure of N-terminal Pex14p upon ligand binding, giving rise to an alternative role of 
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Pex19p, in which the protein might serve as a protective “cap” for Pex14p until it is replaced 
by Pex5p.  
 
 
4.10  Short summary and further perspectives 
 
The complex structure of N-terminal Pex14p with Pex5p provides details about molecular 
recognition during the first steps of peroxisomal import. We were able to demonstrate that the 
binding of amphipathic ligands to Pex14p is flexible in target recognition, leading to a 
broader spectrum of possible ligands, but selective enough to discriminate between these 
ligands. As demonstrated on the analysis of the regular orientation of Pex19p, these results 
can help to explain and probably to predict further possible N-terminal Pex14p interaction 
motifs. Based on the characteristic properties of the N-terminal domain we introduced a 
model for the role of the Pex14p-Pex5p interaction. Further investigation are needed, 
especially the confirmation of the luminal localizaton of the N-terminal domain. A further 
major goal will be the transfer of our results into an in vivo model system, answering 
questions such as if Pex19p and Pex5p, two key proteins at different stages of the peroxisomal 
life cycle, converge at Pex14p or interact successively. Another interesting point to be 
specified is the question if the inverse Pex14p-Pex19p binding is biological relevant or has 
evolved accidentally. Furthermore, investigation of the Pex13p-Pex14p interaction and the 
determination and quantification of the minimal Pex14p binding site in Pex13p will be 
needed. Finally, we introduced the conserved the N-terminal domain as a new modular 
protein structure. 
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6 Appendix I - NMR spectroscopy 
 
Besides the application of NMR in medicine, chemistry, it is also commonly used in structural 
biology. So far X-ray crystallography and NMR spectroscopy are the only techniques that 
allow an insight in the structure of proteins at an atomic resolution (Wüthrich, 1986). 
Although the practical application of NMR spectroscopy is restricted to smaller molecules 
and the process of structure determination is still not automated to an extent comparable to X-
crystallography, the method provides a number of advantages. In addition to the 3-
dimensional structure which provides the basis for further functional analysis, NMR gives an 
insight in the dynamic processes (reviewed by Kay, 1998) of molecules in solution and the 
study of molecular interactions(Zuiderweg, 2002).  
 
 
6.1   Basic principles of NMR 
 
NMR spectroscopy is based on an intrinsic quantum mechanic feature of nuclei known as 
spin, which is determined by a nuclear spin quantum number I. A nucleus with a non-zero 
spin interacts with an external magnetic field, resulting in a splitting of its energy levels. The 
number of levels is defined by the magnetic quantum number m and can adopt numbers of 
integer steps from –I to +I (Zeeman levels).  The most commonly used nuclei in NMR (e.g. 
1H, 15N and 13C) have a spin number of ½ and split in two possible energy levels, i.e. parallel 
(m= + ½) and antiparallel (m= - ½). In addition, nuclei with a spin possess a proportionally 
linked nuclear magnetic moment which aligns with the magnetic field. The energy levels of a 
nucleus in a magnetic field are described by 
 
000 BmBIBE zz hγγμ −=−=−=  
 
where µz and Iz are the z-component of the magnetic moment µ and spin I along the external 
magnetic field and γ the gyromagnetic ratio. Transitions between energy stages can be 
stimulated by external radiation of a certain frequency called Larmor frequency which is 
identical to with the frequency of precession of the magnetic moment around the main axis of 
the static magnetic field. The Larmor frequency depends on the gyromagnetic ratio and the 
strength of the external magnetic field. 
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At equilibrium the different energy stages are populated unequally whereby the difference is 
given by the Boltzmann distribution. Lower energy levels are slightly more preferred than 
higher ones leading to a bulk magnetization of the sample parallel to the static magnetic field. 
This macroscopic magnetization is called longitudinal magnetization and characterized by the 
strength of the magnetic field, the number of involved spins and the temperature. In a simple 
NMR experiment the equilibrium longitudinal magnetization Mz,eq is disturbed by an external  
electromagnetic pulse. If the magnetic field of this pulse is applied vertically to the static field 
transverse magnetization Mx,y can be introduced. A pulse that leads to a complete 
transformation of longitudinal to transverse magnetization is called 90° pulse.  
 
6.2   Chemical shift 
 
The deflection of the static magnetic field by the surrounding electronic environment of a 
nucleus leads to a slightly different Larmor precession. This effect is called chemical shift δ 
and represents one of the basic parameters of NMR-spectroscopy. It determines the dispersion 
of signals in a NMR spectrum. The chemical shift is measured in ppm (parts per million) to a 
reference frequency and is defined by 
 
reference
referencesignal
ω
ωωδ −=  
 
The chemical shift can be exploited for polypeptide backbone angle prediction (Φ and Ψ) 
leading to an improvement in the quality of protein structures (Cornilescu et al., 1999). 
 
6.2.1   Scalar coupling experiments 
 
Spins close to each other exert an influence on each other’s magnetic field. This effect can be 
observed by NMR spectroscopy and it provides information about the chemical environment 
of the nucleus. Interactions mediated through chemical bonds are called scalar or J couplings.  
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Fig 6.1: Typical values for one- and 
two bond scalar couplings (1J and 2J) 
in polypeptides. Numbers in red are 
given in Hertz (Hz) and shown at top 
of the bond 
 
The scalar coupling allows the transfer of magnetization between nuclei coupling with each 
other as long as the distance is not greater than three bond lengths. Beside the nuclear 
Overhauser effect (NOE) scalar coupling is one of the most important mechanisms exploited 
in NMR spectroscopy.  
 
6.3   Dipolar coupling experiments 
 
Dipolar couplings mediate spin interactions through space and depend on the internuclear 
distance between two spins and its orientation to a static magnetic field. NOE and relaxation 
are phenomena derived from dipolar couplings. 
 
6.3.1   NOESY experiments 
 
NMR protein structure determination derives mainly from proton-proton distance restraints 
calculated from the intensities of NOE signals. The nuclear Overhauser effect is a result of 
spin-spin cross relaxation and depends on the distance between two dipolar coupled spins.  
The relation between signal intensity I and the distance between two nuclei i and j is 
approximately 
6
1)(
ij
ij r
NOEI ∝  
 
The distances are defined by mathematical integration of the NOE signal. Alternatively a 
qualitative estimation of its intensity is feasible but requires a reference.  To avoid signal 
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overlap three dimensional 13C and 15N-edited NOESY experiments are performed. For 
structural analysis of complexes between a labelled protein and an unlabelled ligand, edited-
filtered NOESY experiments are applied. This allows either to select or to suppress the 
evolution of magnetization of protons bound to a hetero-nucleus.   
 
 
 
 
 
 
 
 
 
 
 
6.3.2   Relaxation and protein dynamics 
 
After the disturbance by an external radio pulse the system of spins aims to return to 
equilibrium. Equilibrium is reached when the longitudinal magnetization is restored to a 
certain value (determined by the population of energy levels predicted by the Boltzman 
distribution) and transverse magnetization is zero. The first process is called longitudinal or 
spin-lattice, the second transverse or spin-spin relaxation. Longitudinal relaxation occurs via 
transition of spins from higher to lower energy levels or vice versa until the equilibrium 
population is reached. The time constant of this process is T1. Transverse relaxation is the loss 
of phase coherence of spins and results in the vanishing of transverse magnetization. Both 
phenomena are induced by random, time-dependent interactions, mainly dipolar interactions 
and chemical shift anisotropy, caused by the thermal motion of the molecule, i.e. random 
tumbling of molecules or molecular flexibility. A measure for the speed of the tumbling of a 
molecule is τc the rotational correlation time. It describes the time that it takes for the 
molecule to reorient, which is much shorter for small molecules compared to large molecules 
such as proteins. For small molecules, with a fast tumbling rate T1 is equal to T2. For proteins, 
with larger correlation times, T2 is smaller than T1 (Fig. 6.2).  
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Fig. 6.2:  Logarithmic plots of T1 and T2 
times. Curves are given for proton 
resonance frequencies of 400, 600 and 800 
MHz 
 
For larger molecules T2 is inversely proportional to τc which itself is proportional to the 
molecular weight. Thus T2 relaxation times provide a tool to estimate the molecular weight of 
proteins in solution. Another application of relaxation times is the characterization of the 
dynamic properties of a molecule. For proteins relaxation rates are usually determined for the 
backbone amide nitrogens. Residues with ratios of T1/T2 significantly different from the 
average indicate different dynamic properties und show regions of high flexibility or 
structured regions, respectively.  
 
 
6.4   NMR structure determination 
 
NMR structure determination involves information obtained from various experiments. 
Although the main sources for structural restraints are short proton-proton distances derived 
from NOESY (Nuclear Overhauser and Exchange Spectroscopy) experiments, additional 
information, e.g. dihedral angles, residual dipolar couplings or solvent exchange, help to 
complement the final structure.  
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Table 6.1: NMR observables for structure determination. 
Observable Information 
Chemical shifts (1H, 13C, 15N, 31P) Assignments, secondary structure 
J-couplings (through bond) 
3J(HN, Ha), 
Dihedral angles 
NOE (through space) Interatomic distances (< 5A) 
Residual dipolar couplings (1H-15N) Bond projection angles 
Solvent exchange (HN) Hydrogen bonds 
 
 
6.4.1   Backbone and Side chain assignments 
 
Assignments of proteins are in general carried out on uniformly and isotopically labelled 
protein samples. To obtain a suitable sample, protein expression is carried out by bacteria in 
minimal media containing 15N and/or 13C isotopes as the only nitrogen and/or carbon source. 
The protons of an isotopically labelled sample are correlated with the resonances of 
heteronuclei, providing the advantage of clearer spectra and less overlap of signals. 
 The sequence specific assignment of the protein backbone is done under application of triple 
resonance experiments, correlating the Cα and/or Cβ atoms with the amide nitrogen and 
proton of either the same residue i and/or the previous residue i-1 in the polypeptide chain. 
Double labelled protein samples are a prerequisite for these experiments. The magnetization 
is transferred directly via the covalent peptide bond leading to a high sensitivity. 
 
 
Fig. 6.3: Overview of NMR backbone 
experiments. Correlated spin system are 
boxed in the same manner as the 
associated experiment. 
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Usually, a set of four different experiments is recorded: the HNCA-, HN(CO)CA-, CBCANH 
and CBCA(CO)NH). HNCA and CBCANH experiments reveal the chemical shifts of the 
intraresidual carbon atom and the previous one. Experiments involving a transfer of 
magnetization over the backbone carbonyl carbon (CO) do not allow the intraresidual 
magnetization between HN and Cα. Thus, only observation of sequential cross peaks is 
possible.  Comparison of peaks can be used for a complete “walk” over the protein sequence 
(or at least until a proline is reached) allowing the connection of residues and assignment of 
their HN, N, Cα and Cβ atoms.  
Side chain assignments are defined via different TOCSY experiments (total correlation 
spectroscopy). In general such an experiment divides the magnetization over the whole spin 
system of an amino acid via successive step by step transfer. Depending on the experimental 
setup the aliphatic carbon resonances of ((H)CC(CO)NH) or the side chain protons 
(H(CCCO)NH) of residue i-1 can be correlated to the backbone amide of amino acid i. 
Intraresidual proton and carbon resonances are correlated via a HCCH-TOCSY. Fig. 1.9 
provides an overview. 
 
 
 
Fig. 6.4: Overview of NMR side chain 
experiments. Correlated spin system are 
boxed in the same manner as the 
associated experiment. 
 
 
 
6.4.2   Secondary structure  
 
The knowledge about the chemical shifts of the atoms of a certain residue allows to conclude 
on the chemical enviorement in which this residue is embedded. A common tool to 
investigate the secondary structure or backbone conformation of a protein is the secondary 
chemical shift, which represents the difference of the observed chemical shift to a coiled coil 
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value. Normally secondary chemical shifts from 1H or 13C shift are used to identify or predict 
secondary structure elements in proteins. 
Another application to determine the secondary structure of polypeptide chains is the analysis 
of 3J coupling constants of three covalent bounds, which provides information on the 
geometry of a polypeptide chain. The magnitude of J is a function of the torsion angle Φ and  
is described by the Karplus relation (Karplus, 1959). 
 
CBAJ +−Φ−−Φ=Φ )60cos()60(cos)( 2  
 
where A, B and C are empirical constants and different for every type of torsion angle. Most 
commonly, the torsion angle Φ of the protein backbone (HN-N-Cα-Hα) is determined by this 
method.  
 
 
6.4.3   Residual dipolar couplings 
 
Residual dipolar coupling (RDC) experiments provide information on the orientation of 
internuclear, usually one-bond vectors relative to the magnetic field (reviewed by Bax, 2003). 
Similar RDC values indicate similar orientations. Thus, residual dipolar coupling, do 
complements the local information given by NOE and J-coupling by restraining all bond 
orientation to a common frame.  The source of this structural information is the direct spin-
spin interaction between two nuclei. It depends on the internuclear distance and its orientation 
to a static magnetic field. In the solid state this leads to large dipolar splittings and linewidth 
since dipolar couplings of organic macromolecules are in the kHz range. In solution, dipolar 
couplings of a molecule average to zero. However, in a dilute liquid crystalline medium 
moderate molecular alignment is achieved, resulting in residual dipolar couplings of a few 
Hertz. RDC restraints are employed directly in structure refinement or as a judgement of 
structural quality (Tjandra and Bax, 1997). 
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6.4.4   Solvent exchange 
 
The amide protons of a protein are exchanged with the surrounding solvent. If the solvent 
consists of 100% deuterium, this exchange can be monitored by an 15N,1H-correlation 
experiment. The rate of exchange of certain residues reflects their accessibility to the solvent 
and gives information about which parts of the protein are buried or involved in hydrogen 
bond formation (Huyghues-Despointes et al., 2001). A common application is to compare the 
exchange of free protein versus a complex. The amides that become protected in the complex, 
are assumed to be in the binding site.  
 
6.4.5   Structure calculation 
 
The information obtained by the experimental procedure described above (see table 1.2) is 
supplemented with physically possible values for bond length, bond angles and van der Waals 
radii of molecules and applied to a simulated annealing protocol, e.g. by using the program 
ARIA (Linge et al., 2001). The calculation is an iterative process, searching for an energy-
minimized structure ensemble (or NMR ensemble) determined by the given experimental 
data. The quality of the structure is determined by the similarity of the calculated structures as 
well as by the distribution of dihedral angles in a Ramachandran plot or the Q-factor derived 
from the RDCs. 
 
 
6.5   Interaction studies 
 
Compared to other techniques, e.g. isothermal calorimetry, NMR spectroscopy does not only 
provide binary information about binding or non-binding, but also reveals structural details of 
the binding process. The most frequently used method is chemical shift perturbation mapping 
via 15N,1H-correlation spectra. Thereby the spectra of a free and bound protein are compared 
by superimposition. Residues involved in binding or structural rearrangements upon binding 
experience a change in chemical environment and are strongly perturbated. In addition to the 
mapping of the interaction interface, titration experiments can be carried out, providing 
information about the interaction kinetics. The appearance of such an NMR spectrum depends 
on how rapidly the bound and free form of a complex exchange. Weak interactions, with high 
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Kd values have fast exchange rates compared with the differences in NMR parameters 
(chemical shift, relaxation rate, etc.) and show a spectrum representing the weighted average 
of free and bound ligand. This leads to an observable movement of peaks during titration 
(Fig.6.4). Strong interactions are often in the slow exchange regime, showing separate spectra 
for both forms and are characterized by an abrupt skip of free-state to bound-state peak shifts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A23
L73 
A32
A15 
Fig. 6.4: Superimposition of 1H,15N correlation spectra of N-terminal Pex14p in complex with 
increasing Pex19p peptide concentrations. The interaction is in fast exchange on a NMR time scale. 
Residues involved in ligand binding experience a strong chemical shift perturbation (A32). Residues 
outside the interaction interface stay stationary (A15, A23, L73). 
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7 Appendix II – Additional data 
7.1   Mass spectrometry  
 
 
 
 Fig. 7.1 undigested control 
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Fig. 7.2: N-terminal digestion 
 
 
Fig 7.3: C-terminal digestion 
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7.2  Additional Spectra 
 
 
Fig 7.4: 1H1H NOESY (A) and TOCSY (B) spectrum of free Pex19p (aa 66-77) in D2O at 500 
MHz and 303K. Mixing times were 500ms (NOESY) and 80ms (TOCSY) respectively. Black 
color indicates positive, red color negative peak intensities. Only intraresidual NOEs can be
observed
A 
B 
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